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Fifteen Thoroughbred geldings on an eight month weight gain study were used to 
evaluate 1) the effects of weight gain and diet on body area (neck, withers, shoulders, 
ribs, loin, tailhead) condition scores, and 2) the effects of weight gain, diet, and 
exercise on serum concentrations of tumor necrosis factor-α.  The body condition 
scoring system developed in Quarter horse was slightly modified for use 
Thoroughbred geldings and involved developing prediction equations that utilized a 
smaller subset of the body areas.  Horses at a BCS of 4 were found to be at a higher 
risk of inflammation that horses at a BCS of 7.  The degree of inflammation was 
similar between horses fed either a high starch and sugar diet or high fiber and fat 
diet, indicated by similar TNF concentrations.  Restricting daily exercise for two 
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Chapter 1: Introduction 
 Body condition scoring (BCS) is a subjective method of estimating 
subcutaneous fat cover in many livestock species and is one of the most widely used 
indices of energy balance in equine feeding management.  The most commonly used 
equine BCS method was developed by Henneke et al. (1983) in pre-parturient Quarter 
horse mares.  Fat cover of six discrete body areas; neck, withers, shoulders, ribs, loin, 
and tailhead was scored on a scale of 1 (thin) to 9 (fat) by physical palpation and 
visual assessment and then averaged for a mean BCS.  The Henneke system has since 
been applied to all breeds, ages, and genders of horses, without determining if the 
system accurately describes body area fat accretion in these different classes of 
horses, if all classes of horses accrue subcutaneous fat in the same locations or if 
different types of diets have effects on body area fat accumulation.    
Body condition scoring is an inexpensive and easily applied method for 
determining temporal changes in nutritional status.  However, a valid BCS system is 
required to accurately assess these changes.  Body condition scoring is an important 
management tool that can be used to prevent obesity.  To date, obesity in horses has 
been linked with the development of life threatening metabolic conditions such as 
laminitis (Jeffcott et al., 1986; Fontaine et al., 2001) and hyperlipemia (Jeffcott et al., 
1985; Hughes, 2004).  Obesity in horses is often the result of a lack of knowledge on 
the owners’ part about the serious risks associated with unhealthy levels of fat in their 
animals.  Weight gain is positively correlated with increasing systemic concentrations 




(Hotamisligil et al., 1995) and horses (Vick et al., 2007), which are produced by the 
accumulating adipose tissue.  In humans, an increase in TNF results in a low grade 
inflammation (Sethi et al., 1999) that precludes development of the metabolic 
diseases of obesity (Permana et al., 2006; Skurk et al., 2004).  Since the obese equine 
also appears to be at risk for metabolic diseases (Johnson et al., 2002; Kronfeld et al., 
2006; Treiber et al., 2006), a similar mechanism of action is probable (Vick et al., 
2007).   
Based on the importance of understanding both how horses accrue body fat 
and the link between excessive body fat and disease, the objectives of these studies 
were to:  
1) Determine the accuracy and precision of the Henneke BCS system for 
Thoroughbred geldings  
2) Assess the effect of dietary energy source on the distribution of subcutaneous 
body area fat accretion 
3) Determine if a smaller subset of body areas could be used to accurately 
predict the overall mean BCS for the Henneke BCS system in Thoroughbred 
geldings 
4) Determine if BCS gain is associated with serum concentrations of TNF 
5) Assess the effects of dietary energy source on serum TNF concentrations 
6) Determine whether cessation of daily exercise in horses fed to gain weight 





Chapter 2: Review of Literature 
 The ability to quantify stored body fat is important for nutritional, 
reproductive, and health management of livestock animals.  The most common 
method reported in the literature for assessing body fat in horses is body condition 
scoring, a qualitative assessment of subcutaneous fat cover.  Other techniques that are 
used, but are less common, include ultrasonography and body mass index.  Managing 
horses properly involves the ability to maintain them at a healthy body condition and 
weight (Johnson, 2002; Treiber et al., 2006), and this in turn requires tools that are 
easily applied to large animals under field conditions.   
 The most common cause of unhealthy levels of fatness in horses is the feeding 
of too much grain in comparison to the level of physical activity a horse exerts 
(Johnson, 2002).  This is often compounded with a lack of knowledge on the 
manager’s part about how to assess body fat.  Overfeeding can come in the form of 
concentrates, forages or lush pasture and because horses are often maintained in large 
group-feeding situations, horses that are prone to weight gain may need special 
attention during feeding to avoid obesity (Johnson, 2002).  Maintaining horses at a 
healthy condition is important because there are several metabolic disorders 
associated with obesity in horses (Jeffcott et al., 1986; Hughes, 2004; Kronfeld et al., 
2006; Treiber et al., 2006).  Therefore, using a system such as body condition scoring 
to manage feed and exercise needs may aid in the prevention of metabolic disorders 




METHODS FOR ASSESSING BODY COMPOSITION IN THE HORSE 
Body Condition Scoring 
 Body condition scoring (BCS) systems estimate subcutaneous fat cover by 
dividing the continuous scale of fat deposition into categories based on specific 
characteristics (Burkholder, 2000; Evans, 1978).  This is done through both visual 
assessments and physical palpations.  Most systems use low scores to indicate an 
animal with minimal fat cover and easily visible bony structures, mid range scores to 
indicate an animal with bony structures that can be easily felt but not seen, and high 
range scores to indicate an animal whose bony structures are difficult to feel 
(Burkholder, 2000).  Generally, mid range scores are the most desired, with athletes 
slightly lower and breeding animals slightly higher (Kronfeld, 1997).   
Benefits and Limitations.  Body condition scoring is the most often used method for 
determining fat cover in research publications, most likely due to ease of use, little 
expense, and no required equipment.  Estimating an animal’s fat cover is necessary 
for monitoring health and nutrition status as well as enabling the implementation of 
suitable feed and exercise management strategies that will bring about the optimal 
condition of that particular animal (Kronfeld, 1997).  Within the equine species, 
healthy body weights range from 100 kg in Miniature Horses to 1000 kg in draft 
horse breeds, therefore, body weight (BW) alone is not sufficient for determining 
adequate nutritional status and health.  In comparison, BCS are independent of frame 
size, allowing for a better assessment of health than BW alone (Burkholder, 2000).  
Body condition scoring is a good method of estimating stored body fat because it uses 




indicators such as BMI.  However the benefit of the BMI measurement is that it is an 
indicator of visceral fat, whereas BCS only takes into account subcutaneous fat. 
Body condition scoring systems are highly subjective when not accompanied 
by an unambiguous protocol, including both specific characteristics of each score and 
instructions for use (Evans, 1978).  Therefore, in order to be valid, a BCS system 
should demonstrate three qualifications: repeatability, reproducibility, and 
predictability (Burkholder, 2000).  Repeatability is a test of the system’s precision; 
such that one assessor repeatedly assigns the same score to a given animal that is 
maintaining condition.  Reproducibility is a test of between-assessor variability, such 
that two or more assessors assign the same score to one animal, while predictability is 
the ability of a BCS system to accurately reflect the fat cover of an animal.  The main 
limitation of a BCS system is its subjective nature, thus valid results require user 
knowledge and familiarity of the judge with each system.  Subjectivity is reduced and 
reliability of scores increased when the assignment of scores is conducted according 
to specific protocols (Burkholder, 2000).     
Leighton-Hardman.  The first published BCS system for horses was that of 
Leighton-Hardman (1980), which defines condition as the amount of subcutaneous 
fatty tissue present in a given animal (Table 1).  This system identifies three areas of 
fat accumulation: the pelvic area as viewed by standing directly behind the horse, 
backbone and ribs, and neck area immediately cranial to the withers.  The scale is 
from 0 (thin) to 5 (fat) with half point demarcations, resulting in an 11 point scale, 
although only whole scores are defined.  Basic user instructions include visuals and 




assessment is conducted on the pelvic region first, and the score given can be adjusted 
by a half score if the score given to the back/ribs and neck area differs from the pelvic 
score by one point or more.  Therefore the pelvic region score receives the greatest 
weight when calculating the final score.   
The drawbacks of this system include that it utilizes only 6 whole scores, 
which may not be specific enough for research purposes.  Additionally, there is no 
validation or explanation for using an adjusted pelvis score, which gives the pelvic 
score more weight than the other body areas being scored. 
Table 1. Body condition scores as described by Leighton-Hardman (1980) 
 Body Areas 
Score Pelvis Back and Ribs Neck 
0: Very Poor Deep cavity under tail and 
either side of croup.  Skin 
drawn tightly over pelvis 
with no tissue detectable 
beneath. 
Individual processes sharp to 
touch and very clearly 
defined.  Skin drawn tightly 
over clearly defined ribs. 
Ewe neck, very 
narrow and slack at 
base. 
1: Poor Croup and pelvis well 
defined.  No fatty tissue 
present but skin is supple. 
Deep depression under tail. 
Individual processes of the 
backbone sharp to touch and 
clearly defined.  Ribs clearly 
visible. 
Ewe neck, narrow 
and slack at base. 
2: Moderate Croup well defined but some 
fatty tissue felt under the 
skin.  Pelvis felt easy.  Slight 
cavity under the tail. 
Backbone is covered.  
Individual processes not 
apparent but can easily be 
felt with pressure.  Ribs just 
visible. 
Narrow but firm. 
3: Good Fatty tissue covering whole 
area giving a rounded 
appearance without any 
'gutter'.  Skin appears smooth 
but pelvis easily felt 
Vertebrae well covered but 
without a 'gutter'.  Backbone 
easily felt with pressure.  
Ribs just covered 
Firm, but with no 
crest except for 
stallions. 
4: Fat Pelvis buried in soft fatty 
tissue. 'Gutter' to root of tail.  
Pelvis felt only with firm 
pressure. 
Gutter' along length of 
backbone.  Ribs well 
covered by fatty tissue.  
Bone structure felt only with 
firm pressure. 
Wide and firm, with 
folds of fatty tissue 
present.  Slight crest 
even in mares. 
5: Grossly Fat Pelvis buried in fatty tissue.  
Deep 'gutter' to root of tail.  
Skin distended. No part of 
pelvis felt even with firm 
pressure 
Deep 'gutter' along 
backbone.  Ribs buried in 
fatty tissue.  Bone structure 
cannot be felt.  Back more 
like a table. 
Very wide and firm, 
with folds of fatty 
tissue present.  






Carroll and Huntington.  Carroll and Huntington (1988) adapted the Leighton-
Hardman (1980) system by adding detailed descriptions of each score (Table 2).  In 
addition, they suggest a more concrete overall condition score calculation, where 
pelvic score is adjusted by 0.5 if it differs by 1 or more points from the back or neck 
scores.  The primary goal of their work was to develop nomograms for BW prediction 
from BCS and height, and so the 0-5 scale was chosen for its simplicity when 
compared to a 1-9 scale (Henneke et al., 1983).  They used the same score 
descriptions described by Leighton-Hardman.   
 An evaluation of the 0-5 scale was carried out, which included condition 
scoring and BW measurement of 30 horses by one of the authors and several other 
horsemen, unfamiliar to condition scoring.  The number of other horsemen used to 
score the horses was not reported.  Condition score results between the one author 
and the other horsemen were the same in 65% of the horses and the maximum 
difference was 0.5 scores.  The authors do not report statistical agreement of scores, 
or the correlation coefficient in their paper, which is a drawback to their study.  There 
is also no defined requirement in the literature for either agreement between judge 
scores or maximum allowable difference; therefore although the authors claim that 
their system had good correlation, there is no way of determining if it is indeed 
biologically acceptable.  A second evaluation included condition scoring, body 
weight (BW), and height measurements from 20 non-pregnant Thoroughbred (TB) 
mares.  Body weight was calculated from the nomograms and compared to the 
measured BW of horses in the same condition and height categories from the sample 




between calculated and measured BW, while score had a correlation coefficient of 
0.704 with BW. 
Table 2. Body condition system for horses as described by Carroll and 
Huntington (1988) 
Score Neck Back and Ribs Pelvis 
0: Very Poor Marked 'ewe' neck.  
Narrow and slack at 
base. 
Skin tight over ribs.  
Spinous processes sharp 
and easily seen. 
Angular pelvis- skin 
tight.  Deep cavity under 
tail and either side of 
croup. 
1: Poor ‘Ewe' neck.  Narrow 
and slack at base. 
Ribs easily visible.  Skin 
sunken either side of 
backbone.  Spinous 
processes well defined. 
Rump sunken, but skin 
supple.  Pelvis and croup 
well defined.  Deep 
depression under tail. 
2: Moderate Narrow but firm. Ribs just visible.  
Backbone well covered.  
Spinous processes felt. 
Rump is flat on either 
side of backbone. Croup 
is well defined, some fat.  
Slight cavity under tail. 
3: Good No crest (except in 
stallions). 
Ribs just covered- easily 
felt.  No 'gutter' along 
back.  Spinous processes 
covered, but can be felt. 
Pelvis covered by fat and 
rounded.  Pelvis easily 
felt. 
4: Fat Slight crest.  Wide 
and firm. 
Ribs well covered- need 
firm pressure to feel.  
'Gutter' along backbone. 
Gutter' to root of tail.  
Pelvis covered by soft 
fat- felt only with firm 
pressure. 
5: Very Fat Marked crest.  Very 
wide and firm.  Folds 
of fat. 
Ribs buried- cannot feel.  
Deep 'gutter'.  Back 
broad and flat. 
Deep 'gutter' to root of 
tail.  Skin distended.  
Pelvis buried- cannot be 
felt. 
Rudman and Keiper.  Rudman and Keiper (1991) further modified the 0-5 scale 
through the development of a visual system to monitor the body condition of feral 
ponies on Assateague Island, MD (Figure 1).  A visual BCS system is much more 
applicable to feral horse populations since it is usually not possible to physically 
palpate them.  It may also be applicable to large ranching or farming operations that 
keep more animals than is possible to physically palpate.  The authors utilized the 
same three body areas: the pelvic area, back/ ribs, and neck.  They developed a 




on the prominence or rounding of the bone structures- ribs, vertebrae, point of hip, 
and whether the neck is “ewe” or “cresty”.  A major flaw of the system includes the 
fact that differences in conformation, muscle tone, and condition all change the 
appearance of an animal and the rounding and appearance of bone structures.  
Without physical palpation it may be hard to tell whether a particular animal’s shape 
is influenced by conformation, muscle tone, or condition.    
 
 
Figure 1.  Body condition scores as defined by Rudman and Keiper (1991) 
 
 
Henneke.  The most common BCS system used today in research and management 
was developed in pre-parturient Quarter Horse mares (Henneke et al., 1983) as a way 
to accurately compare stored body fat by assigning a subjective score of fat accretion 
at six different body areas (Table 3).  Sites of subcutaneous fat storage (Figure 2) 
specific to horses were determined by single time point observations of several 
mature horses, of mixed body condition and gender.  A preliminary system was 
developed by Henneke (1981) and tested on 20 horses of Quarter Horse breeding by 
faculty, staff, and graduate students of the Texas A&M Animal Science Department.  




evaluation.  Henneke identified six specific body areas of subcutaneous fat deposition 
as the neck, withers, behind the shoulders, ribs, lumbar spinous processes, and the 
tailhead.  This condition scoring system defines a range of 1 (thin) to 9 (obese), with 
measurements in 0.5 units.   
 Body condition scores were compared by Henneke et al. (1983) to percent 
body fat by ultrasonic scans of rump fat thickness based on the methods of Westervelt 
et al. (1976).  Correlations were run between BCS, BW, height, heart-girth, 
BW/height, heart-girth/height, and percent body fat.  Body condition score was highly 
correlated to percent body fat, while there were no significant correlations between 
BW, height, or heart-girth measurements and percent body fat.  Body weight/height 
and heart-girth/height were also significantly correlated to percent body fat.  These 
results indicate that when used alone, single measurements of body size do not 
provide adequate estimates of body fat; however, ratios of these measurements can be 
used for this purpose.   
Different breeds of horses were bred for different purposes- racing, pulling, 
pleasure riding, etc.  These purposes may have had effects on breed specific inherent 
levels of muscling and bone structure, and these differences may affect the 
assignment of a BCS.  The Henneke BCS system was primarily developed for use in 
reproductively active Quarter Horse mares, whose conformation may not only be 
affected by breed specific muscling but also by the weight of the fetus (Henneke et 
al., 1983).  Because conformational differences between breeds may have significant 
impacts on scores, Henneke (1981) suggests that instead of averaging body area 




depending on these conformational differences.  However, no weighting factors were 
suggested.  Throughout the rest of this paper, BCS will refer to that determined by 
using the Henneke method, unless otherwise specified. 
The benefits of using the Henneke BCS system include that it offers more 
categories for classifying animals, as well as identifying more body areas that accrue 
body fat than the other BCS systems.  The Henneke system is the most often used 
BCS system in equine research because it offers the most flexibility when assigning 
scores, and it also has more comprehensive descriptions than the other BCS systems. 
Table 3. Body condition scores as described by Henneke (1983) 
Score 
Description 
1: Poor Animal extremely emaciated.  Spinous processes, ribs, tailhead, tuber coxae and 
ischii projecting prominently.  Bone structure of withers, shoulders, and neck easily 
noticeable.  No fatty tissue can be felt. 
2: Very Thin Animal emaciated.  Slight fat covering over base of spinous processes, transverse 
processes of lumbar vertebrae feel rounded.  Spinous processes, ribs, tailhead, tuber 
coxae, and ischii prominent.  Withers, shoulders, neck structures faintly discernible.  
3: Thin Fat buildup about halfway on spinous processes, transverse processes cannot be felt.  
Slight fat cover over ribs.  Spinous processes and ribs easily felt.  Tailhead 
prominent but individual vertebrae cannot be visually identified.  Tuber coxae 
appear rounded, but easily discernible.  Tuber ischii not distinguishable.  Withers, 
shoulders, and neck accentuated. 
4: Moderately Thin Negative crease along back.  Faint outline of ribs discernible.  Tailhead prominence 
depends on conformation, fat can be felt around it.  Tuber coxae not discernible.  
Withers, shoulders, and neck not obviously thin. 
5: Moderate Back level.  Ribs cannot be visually distinguished but can be easily felt.  Fat around 
tailhead beginning to feel spongy.  Withers appear rounded over the spinous 










Table 3 continued. Body condition scores as described by Henneke (1983) 
Score Description 
6: Moderately Fleshy May have slight positive crease down back.  Fat over ribs feel spongy.  Fat around 
tailhead feels soft.  Fat beginning to be deposited along the side of the withers, 
behind the shoulders and along the sides of the neck. 
 
7: Fleshy May have a crease down the back.  Individual ribs can be felt, but noticeable 
filling between the ribs with fat.  Fat around tailhead is soft.  Fat deposited along 
withers, behind shoulders, and along neck. 
 
8: Fat Crease down back.  Difficult to feel ribs.  Fat around tailhead very soft.  Area 
behind shoulder filled with fat.  Noticeable thickening of neck.  Fat deposited 
along inner thighs. 
 
9: Extremely fat Obvious crease down back.  Patchy fat appearing over ribs.  Bulging fat around 
tailhead, along withers, behind shoulders and along neck.  Fat along inner things 
may rub together.  Flank filled with fat. 
 
 
Figure 2. Body areas described by Henneke et al. (1983). 
 
Body Mass Index 
 Body mass index (BMI) is rarely used as a measure of body fat in equine 
research; however, it is frequently used in human nutrition consultations.  Donaldson 




horses, to correlate body fat to α- melanocyte stimulating hormone, an appetite 
control and energy balance hormone.  Body mass index is an easily obtained and 
objective measure of body fat that is possibly more reliable than BCS, due to the 
subjective nature of body condition scoring (Donaldson et al., 2004).  Body mass 
index was found to be a reasonable measure of body fat (r2 = 0.60, p < 0.001).  
Healthy BMIs in horses ranged from 175 to 250, but because BW was calculated 
from a formula (Henneke et al., 1983) and not actual BW, BMI calculations based on 
actual BW might be slightly different.  A drawback of using BMI is that BW may be 
influenced by more than just body fat, and therefore large ranges of BMI may be 
healthy. 
Ultrasound Measurements 
 Ultrasonic measurements of fat cover are frequently used in equine nutrition 
and physiology research.  The original work was done by Westervelt et al. (1976) on 
8 horses and 11 ponies evaluated for fat thickness at the shoulder (directly posterior to 
scapula), rib (5 cm lateral from the spinous processes between the 12th and 13th ribs), 
and rump (5 cm lateral from the midline at the center of the pelvic bone) prior to 
slaughter.  Carcass analysis was performed to determine total body fat by ether 
extract on homogenized carcass samples.  Total body fat for horses was accurately 
predicted by rump fat measurements (r2 = 0.93, p < 0.01), by the equation Y = 8.64 + 
4.70X; where X = cm of rump fat and Y = percent fat.  The equation for ponies was 
determined to be Y = 3.83 + 5.58X.  Body condition scores correlated well to percent 




 A similar study by Kane et al. (1989) looked at site differences along the 
rump.  Five sites were located 10 cm off the midline, at 5 cm intervals starting 6 cm 
from the tailhead.  Site 1 was closest to the tailhead while site 5 was almost at the top 
of the croup.  Ultrasound measurements were made to determine fat thickness at these 
5 sites, and then horses were slaughtered and actual fat thickness determined.  Sites 1-
4 showed good correlation between ultrasound-derived fat thickness and actual body 
fat percentage, with sites 2 and 3 showing the strongest correlations (r2 = 0.98 and 
0.97, respectively).  Derived equations varied greatly between sites, however, 
equations predicted from actual fat (Y = 5.01 + 5.7X) versus ultrasound 
measurements (Y = 2.89 + 5.47X) were most similar at site 2.   
Gentry et al. (2004) found correlation coefficients of 0.87, 0.84, 0.82 and 0.86 
between BCS and back fat thickness at the tailhead, rump, 13th rib, and withers 
respectively.  In this study, light-breed mares at a starting BCS of 7 were fed for 
either BW gain to a BCS of 8.5, or BW loss to a BCS of 3.5, over a 2 mo period, and 
maintained there for 7 mos.  Over the study period, there was little change in back fat 
thickness over the rump area as compared to the other three body areas, indicating 
that rump (correlates to site 5) might not be an accurate indicator of BCS in the horse.  
The tailhead area was the best indicator of BCS, as the tailhead averaged the most 
changes in fat cover, followed by fat cover of both the 13th rib and the withers. 
Relationship between BCS, BW, and Body Fat 
Body condition has been correlated to percent body fat in several studies, as 
well as BW gain required to achieve an increase of one BCS.  Mature horses 




achieved an average daily gain of 1 kg (Heusner, 1993).  Horses increased their BCS 
from a 4 to a 6, with an increase of one BCS correlating to an increase of 16-20 kg 
BW.  These horses averaged a gain of at least one BCS over a three week period.  
Graham-Thiers et al. (1999) demonstrated that a daily intake of 7 Mcal above DE 
resulted in an average daily gain of 0.3 kg, thus suggesting a requirement of 23 Mcal 
DE above maintenance for a one kg increase in BW.  Taken together, these data 
support a requirement of at least 23 Mcal above daily DE for each one kg increase in 
BW, and within the BCS range of 4 to 6 an increase in one BCS requires a BW gain 
of 20 kg.  This BW gain of 20 kg can be achieved with an average daily gain of one 
kg, and would require 20 days of a horse being fed 23 Mcal above daily DE.   
There are broad ranges of percent body fat for each BCS that were identified 
across several breeds.  Hines et al. (1987) estimated Quarter Horse mares at an 
average BCS of 3.4, to have 11-13% body fat.  Estimations of percent body fat in 
BCS 4-5 animals come from Standardbreds (Kearns et al., 2002), Arabians (Lawrence 
et al., 1992), TB broodmares (Vick et al., 2006) and various breeds of mares (Powell 
et al., 2002), which was found to range between 7-11%.  Body fat percentages for 
horses in moderate to moderately fleshy condition (BCS 5-7) have been identified in 
Quarter Horse broodmares (Henneke, 1981; Kubiak et al., 1991) and Standardbred 
mares (Kearns et al., 2001) and ranged from 12% to 24%.  Hines et al. (1987) 
estimated Quarter Horse brood mares at a BCS of 7 to have 16-18% body fat, while 
TB mares at a BCS of 8 averaged 16-18% body fat (Vick et al., 2006), and Quarter 
Horses at a BCS of 9 averaged 16-17% body fat.  However, Powell et al. (2002) 




differences in ranges may be explained two ways: 1) BCS estimates subcutaneous fat 
only and not intra-abdominal fat, therefore breed specific propensity to lay down fat 
in these two distinct areas may affect the range of percent body fat associated with 
that BCS, and 2) breeds may have different propensities to lay down rump fat, 
making the equations less accurate.  To summarize, horses with a BCS of 3-4 have a 
percent body fat of 11-13%; a BCS of 4-5 correlates to a percent body fat of 7-11%; 
BCS 5-7 correlates to a percent body fat of 12-24% body fat; and horses of BCS 7-9 
have a percent body fat of 16-35%. 
THE RELATIONSHIP BETWEEN OBESITY AND METABOLIC 
DISORDERS 
An association between obesity and the onset of metabolic disorders was first 
described in humans as the prevalence of hypertension, hyperglycemia, and gout in 
obese patients (Studien, 1923; Vague, 1947).  More recently, this clustering of 
metabolic diseases with obesity has been termed the ‘Metabolic Syndrome (MS)’ by 
the World Health Organization.  Metabolic diseases of the MS include insulin 
resistance (a metabolic precursor to diabetes) as a central component, diabetes type II, 
hypertension, microalbuminuria, dyslipidemia, and abdominal obesity (Balkau and 
Charles, 1999).  One of the theories relating obesity and metabolic disturbances is 
that adipose tissue is a metabolically active tissue that produces several hormones and 
immune system-associated proteins, or adipokines (Eckel, 2005; Despres, 2003; 
Duncan, 2001; Pickup, 2004).  Of these adipokines, the pro-inflammatory cytokines 
(PIC) are also active innate immune system components with a multitude of functions 




functions include the production of the inflammatory response: including both fever 
(Saigusa, 1990; Kawasaki et al., 1989) and cachexia (Tracey et al., 1988), which are 
physiological responses that promote the recovery of an animal from an infection 
(Hermann et al., 2005; Tracey et al., 1988).  During cachexia, energy intake decreases 
and therefore, one important function of the PIC is to increase energy availability 
through disrupting normal lipid and glucose metabolism (Delano and Moldawer, 
2006; Plata-Salaman, 1998).  Because the sickness response is transient, normal 
metabolism is restored once the animal recovers from infection.   
In obesity, the continual up-regulation of PIC is thought to contribute to the 
development of both dyslipidemia (Hardardottir et al., 1994) and insulin resistance 
(Hotamisligil, 1999).  Through their finding that the onset of diabetes type II was 
consistent with activation of the innate immune system, Pickup et al. (1997) were the 
first to uncover a link between the development of metabolic diseases of obesity and 
inflammatory markers, including both pro-inflammatory cytokines (PIC) and acute 
phase proteins.  Later studies corroborated this evidence through the repeated 
association of the onset of type II diabetes, insulin resistance (a metabolic precursor 
to diabetes type II), or dyslipidemia, or both with increased circulating levels of PIC 
(Bonora et al., 2003; Chan et al., 2002; Schmidt et al, 1999; Pickup and Crook, 1998; 
Pickup, 2004).  One of the PIC associated with increasing adiposity is tumor necrosis 
factor-α (TNF), which will be discussed in detail later in this review.  The metabolic 
diseases of obesity are therefore theorized to result from a chronic low-grade systemic 




Festa et al., 2000; Kershaw and Flier, 2004; Pickup et al., 2004; Trayhurn and Wood., 
2004; Vettor, 2005; Yudkin et al., 1999).  
 The progression of BW gain and onset of obesity in the horse have also been 
linked to several metabolic disorders including insulin resistance (Freestone et al., 
1991a; Hoffman et al., 2003), laminitis (Fontaine et al., 2001; Jeffcott et al., 1986), 
and disrupted lipid metabolism such as hypertriglyceridemia, hyperlipidemia, or 
hyperlipemia (Jeffcott and Field, 1985a; Hughes et al., 2004; Kronfeld et al., 2006).  
Obesity in the equid has not been completely defined; however according to the 
Henneke BCS system, an 8 is considered fat, and 9 as extremely fat.  Obesity may be 
better defined after the mechanisms relating obesity to metabolic disorders in the 
horse are more completely understood. 
The Production of TNF in Adipose Tissue 
 Abdominal adipose tissue is composed of stromal vascular cells 
(preadipocytes, fibroblasts, and non-differentiated mesenchymal cells), differentiated 
adipocytes, and infiltrated macrophages, all of which have the ability to produce TNF 
(Cousin et al., 1999; Xu et al., 2003).  The accumulation of adipose tissue in obesity 
parallels an increased infiltration of macrophages (Weisberg et al., 2003; Wellen, 
2003; Xu et al., 2003).  These macrophages are an important source of TNF 
production in adipose tissue through molecular signaling between adipocytes and 
macrophages (Weisberg et al., 2003; Xu et al., 2003).  Adipocytes produce two 
chemokines that affect macrophage infiltration into adipose tissue: macrophage 
migration inhibitory factor (MIF) and monocyte chemoattractant protein-1 (MCP-1) 




differentiate into macrophages that have enhanced inflammatory activity (Verhoeckx 
et al., 2004).   
 Macrophage migration inhibitory factor is a pleitropic hormone with 
inflammatory effects (Hirokawa et al., 1998) that includes its ability to prolong the 
lifespan of macrophages by protecting them from apoptosis (Bernhagen et al., 1998), 
counteract glucocorticoid- induced suppression of the immune system (Calandra et 
al., 1995; Calandra and Bucala, 1997), and up-regulate TNF expression in immune 
cells (Roger et al., 2001).   Macrophage migration inhibitory factor deficient cells 
have down-regulated TNF receptor expression, and are hypo-responsive to TNF 
induced activity (Toh et al., 2006).  Also, MIF levels are up-regulated in human 
patients with type 2 diabetes (Yabunaka et al., 2000).  Skurk et al. (2005) showed in 
vitro that preadipocytes undergoing differentiation to mature adipocytes secrete MIF, 
and serum concentrations of MIF correlate to BMI in humans.  Additionally, 
adipocytes may have different immunological properties than innate immune cells 
with regard to MIF expression, and may in fact constitutively secrete MIF (Calandra 
et al., 1994, 1998; Martiney et al., 2000). 
Monocyte chemoattractant protein-1 is a hormone that attracts monocytes 
from the blood stream into the adipose tissue (Kanda et al., 2006).  Serum 
concentrations of MCP-1 are significantly correlated to BMI, waist circumference, 
and other inflammatory markers (Kim et al., 2006), and it is up-regulated in the white 
adipose tissue of obese mice (Sartipy and Loskutoff, 2003; Takahashi et al., 2003), 
and humans (Christiansen et al., 2005).  Both macrophage number and MCP-1 




morbidly obese patients (Cancello et al., 2005).  Chen et al. (2005) found that diet-
induced obese mice had elevated adipose tissue expression and plasma levels of 
MCP-1. 
 The major source of MCP-1 in adipose tissue has not been determined, but co-
culturing macrophages with adipocytes results in a significant upregulation of both 
MCP-1 and TNF.  The upregulation of MCP-1 does not require direct contact 
between cell types, as media conditioned from macrophages could induce the MCP-1 
increase from adipocytes (Suganami et al., 2005).  Suganami et al. (2005) did not find 
that undifferentiated adipocytes produced MCP-1, while Wang et al. (2004) did, 
however production increased upon differentiation.  In opposition to this Gerhardt et 
al. (2001) found that MCP-1 release was higher in undifferentiated adipocytes than in 
mature adipocytes.  However, the majority of in vitro MCP-1 release may actually be 
due to the non-adipocyte cells in adipose tissue because endogenous TNF promotes 
an increase in MCP-1 levels from non-fat cells during incubation (Fain et al., 2005).   
It is probable that all cell types in adipose tissue produce MCP-1, and differences in 
experimental results may be due to in vitro conditions that are unable to exactly 
simulate in vivo conditions. 
Increases in MCP-1 protein levels precede increases in TNF expression in 
adipose tissue, suggesting that MCP-1 has a role in TNF expression (Chen et al., 
2005).  However, TNF exposure also stimulates MCP-1 release (Fain, 2006; Bruun et 
al., 2005; Gerhardt et al., 2001).  The drug etanercept (Enbrel®, Immunex Corp., 
Seattle WA), a TNF inhibitor does not reduce MCP-1 production, suggesting that if 




2006).  From this evidence it is plausible that recruitment of macrophages through 
MCP-1 production also results in increased TNF production from macrophages and 
adipocytes, and that this increased TNF then has a feed forward effect on MCP-1 
production and further macrophage recruitment- a feed forward cycle of obesity. 
 Tumor necrosis factor-α production is stimulated by bacterial products such as 
LPS (Chung et al., 2006; Fain, 2006; Flad et al., 1989; Islam et al., 2004) , viruses, 
TNF (Wang et al., 2005) and free fatty acids (Baldeweg et al., 2000).  The 
mechanisms of production and release of TNF in obese adipose tissue are 
incompletely understood, but are most likely due to more than one factor.  It is down-
regulated by drugs such as cyclooxygenase-2 inhibitors (Fain, 2006), 
phosphodiesterase inhibitors (Morjaria, et al., 2006), glucocorticoids (Waage, 1987), 
and thiazolidinediones (Murase et al., 1998).  Lipopolysaccharide (LPS) is a known 
inducer of TNF production and release, from most cell types, and induces a 
concentration dependent stimulation of the synthesis of TNF in hepatocytes 
(Thirunavukkarasu et al., 2006).  In adipocytes, pretreatment with inhibitors to 
proteins in the LPS-stimulated TNF signal transduction cascade does not affect basal 
release levels of TNF, suggesting that basal TNF release is constitutive and 
independent of the LPS-stimulated pathway (Nakajima et al., 2004; 
Thirunavukkarasu et al., 2006).  Kern et al. (1995) also found that adipocyte TNF was 
not stimulated by LPS.  Therefore, adipocyte TNF expression and release may be 
regulated differently from the mechanisms that regulate macrophage TNF expression 




 The major producer of TNF may not be adipocytes, but instead a different cell 
type in adipose tissue.  Sewter et al. (1999) found that stimulation of adipose tissue 
with LPS resulted in a 1000% increase in TNF release, whereas release from isolated 
adipocytes only increased 150%, suggesting that the major TNF producer in adipose 
tissue is not adipocytes.  Chung et al. (2005) and Creeley et al. (2006) also found that 
TNF expression increased in adipose tissue following LPS exposure, and that this 
occurred primarily in the non-adipocyte fraction.  LPS is often used as a TNF 
stimulator to measure tissue TNF production, however, LPS is present only during 
states of acute infection.  Therefore, the increases of TNF seen in obesity may be 
regulated by a pathway that is independent of LPS stimulation.   
Without LPS stimulation, Fain et al. (2004) found that TNF release from 
obese human adipose tissue was primarily attributed to the non-fat cells.  It is also 
possible that that the non-adipocyte fraction of adipose tissue is responsible for 
producing a necessary stimulatory factor that is absent when the cell types are 
separated.  A time dependent study showed that TNF release from isolated adipocytes 
decreased across time, while the non-fat portion of adipose tissue had no change in 
TNF release (Fain, 2006).  These findings were later reinforced through 
demonstrating that TNF release by adipose tissue without lipid was the same as 
adipose tissue with lipid and both were significantly greater than isolated adipocytes 
(Fain, 2006).  Xu et al. (2003) also noted that the majority of TNF mRNA was lowest 
in adipocyte fractions of adipose tissue.  In opposition to these results, Hotamisligil 
(1993) found that when adipocytes were separated from the rest of the adipose tissue, 




fraction.  Overall, these results indicate that the non-adipocyte fraction of adipose 
tissue is most likely the main producer of TNF, and that while adipocytes may 
produce some constitutive TNF, up-regulation of TNF most likely requires a signal 
from the non-adipose fraction (Fain et al., 2004b).     
Effects of Body Fat on TNF 
 In horses, circulating concentrations of TNF have been positively correlated to 
BCS (Vick et al., 2007); however most of the evidence for the effects of body fat on 
TNF come from either rodent or human studies.  In humans, adipose tissue TNF 
mRNA expression correlates with degree of adiposity (Bullo et al., 2003; 
Hotamisligil et al., 1995; Hube and Hauner, 1999; Kern et al., 1995), while BW loss 
correlates with decreasing TNF concentrations (Dandona et al., 1998; Samuelsson et 
al., 2003; Ziccardi et al., 2002).  In rodents, adipose tissue TNF mRNA levels are five 
to ten fold higher in obese vs. lean animals (Hotamisligil et al., 1993).  There are a 
few conflicting results however, as even when adipose tissue mRNA levels of TNF 
are markedly increased, a few authors have not found circulating protein levels to 
increase (Kellerer et al., 1996; Hauner et al., 1998a; Pfeiffer et al., 1997) or adipose 
tissue TNF concentration increased while circulating concentrations did not 
(Hotamisligil et al., 1995).  Interestingly, patients with BMI > 45 (40 to 45% body 
fat), had decreased adipose tissue TNF mRNA (Kern, 1995).     
In addition to changes in TNF mRNA and protein levels, changes in receptor 
levels have been noted in obesity.  However, serum concentrations of the two types of 
receptors show dichotomous results; the 75 kd receptor may increase as much as six 




found in the concentrations of the 55kd receptor.  In opposition to this, Hauner et al. 
(1998b) found that both receptor subtypes were increased 30-40% in obesity.  These 
findings are not completely understood, though Hube and Hauner (1999) 
hypothesized that receptor up-regulation in obesity may be due to 1) a generally up 
regulated TNF system, 2) obesity induced receptor resistance, or 3) that soluble 
receptors serve to neutralize circulating TNF.  
Obesity Associated Metabolic Disorders in the Horse 
Insulin Resistance.  Insulin resistance has been associated with obesity in the horse 
(Hoffman et al., 2002; Vick et al., 2007), although it is more prominent among pony 
breeds than horse breeds (Jeffcott and Field, 1986).  Horses in a BCS range of 4-6 
were not found to be insulin resistant (Nadeau et al., 2006).  Insulin resistance is 
improved with exercise, as 7 days of light training improved insulin sensitivity in 
obese mares (Powell et al, 2002).  Freestone et al. (1991b) noted that obese ponies 
(BCS 8-9) conditioned through exercise for 6 weeks, had decreased plasma insulin 
concentrations.  However, ponies that lost BW through diet alone also had improved 
insulin sensitivity.    
Insulin resistance in humans has been associated with abdominal adipose mass 
and high BMI (Abate et al., 1996; Farin et al., 2006; Festa et al., 2001; Janowska et 
al., 2006; Karter et al., 1996; Mazzali et al., 2006; Salmenniemi et al., 2004; Snijder 
et al., 2004; Weiss et al., 2004).  Following a 17% reduction in weight, obese subjects 
had significantly decreased serum insulin levels, indicating decreased insulin 
resistance (Hotamisligil et al., 1995).  However, Xydakis et al. (2004) showed that 




decreased TNF levels, but did have increased insulin sensitivity.  The lack of change 
in TNF may be due to the only slight decrease in BMI, while the concurrent increase 
in insulin sensitivity indicates that there are multiple factors involved in the regulation 
of insulin resistance in obesity.   
The overproduction of TNF in adipose tissue of obese rodents and obese 
people (Hotamisligil et al., 1995) has been implicated in the development of obesity 
related insulin resistance (Hotamisligil et al., 1993; Hotamisligil et al., 1995).  In 
humans, infusing recombinant human TNF reduces whole body glucose uptake 
(Krogh-Madsen et al., 2006; Plomgard et al., 2005), and patients with the highest 
expression levels of adipose tissue TNF mRNA levels were also the patients with the 
most cases of diabetes, dyslipidemia, and hypertension (Bullo et al., 2003).  You et al. 
(2005) demonstrated that hyperinsulinemia, a metabolic precursor to diabetes type II, 
was positively associated with adipose tissue TNF gene expression in women.  
Additionally, the number of metabolic syndrome components observed in obese 
subjects was negatively associated with circulating concentrations of an alternatively 
spliced TNF receptor, known to antagonize TNF action (Fernandez-Real et al., 2006).  
Thus, Hotamisligil (1999) hypothesized that TNF may directly result in obesity 
induced insulin resistance.   
In vitro TNF results in the loss of insulin’s stimulatory effect on glucose 
uptake into adipocytes (Hauner et al., 1995).  Tumor necrosis factor-α (TNF) may 
induce insulin resistance through increasing serine phosphorylation on insulin 
receptor substrate-1(IRS-1).  Increased serine phosphorylation decreases 




and impairing insulin action (Feinstein et al., 1993; Kanety et al., 1995).  
Administration of a soluble TNF receptor resulted in marked increases in IRS-1 
phosphorylation in the muscle and adipose tissue of obese Zucker rats (Hotamisligil 
et al., 1994).  Tumor necrosis factor-α also acts to decrease insulin receptor, IRS-1, 
and GLUT4 mRNA expression and protein levels, as well as GLUT4 plasma 
membrane translocation (Hauner et al., 1995; Lumeng et al., 2006; Stephens et al., 
1997) .  Thiazolidinediones have a counteractive effect on TNF induced insulin 
resistance (Hernandez et al., 2004; Osei et al., 2005) .  However, while Uysal et al. 
(1997) noted that TNF deficient ob/ob mice had improved insulin sensitivity over 
obese controls, other studies suggest that a TNF knockout is not sufficient to prevent 
obesity associated insulin resistance in rodent models of obesity (Schreyver, 1998; 
Ventre, 1997).  In horses, TNF concentration is positively correlated with the degree 
of insulin resistance (Vick et al., 2007).   
There is significant evidence for the involvement of TNF in the induction of 
insulin resistance of obese individuals, however there may be other mechanisms 
involved in this disorder.  Insulin resistance is considered to be the central component 
of the human metabolic syndrome and therefore it is also possible that insulin 
resistance is also the central component of equine obesity associated metabolic 
disorders.   
Laminitis.  Laminitis is a metabolic disease characterized by inflammation of the 
laminar structures (epidermal-dermal junction) which attach the third phalanx (P3) to 
the inner hoof wall.  Healthy laminae are a metabolically active tissue requiring 




forces of locomotion and BW of the horse.  The equine hoof contains two extensive 
vascular beds that are under hypothalamic control (Hales and Molyneux, 1985; 
Pollitt, 1991): the arteriovenous anastomoses, the shunts that allow blood to bypass 
the capillaries at a faster rate and prevent the horse from developing frostbite (Pollitt, 
1991), and the capillary bed- the microvasculature of the laminar structures (Field and 
Jeffcott, 1989; Hood et al., 1993; Pollitt and Davies, 1998).  In severe cases, P3 can 
completely detach from the hoof wall and rotate through the bottom of the sole.   
 Obesity is a risk factor for the development of laminitis that may allow certain 
triggers to have more of an effect than in lean animals (Alford et al., 2002; Budras et 
al., 2001).  Documented laminitic triggers include the ingestion of large amounts of 
grain (carbohydrate overload) (Garner, et al., 1975), lush grass (Longland et al., 
1999), black walnut shavings (Eaton, et al., 1995; Minnick et al., 1975), endometritis 
(Broome et al., 1992), severe infections (Miller et al., 1983), cortisol dysfunction 
(French, 2000; Johnson, 2004) and obesity (Kronfeld et al., 2006).  Laminitis occurs 
in both a chronic, long term form and an acute form (Cripps and Eustace, 1999).  
The most common method of experimentally inducing laminitis is through 
carbohydrate overload.  Excess carbohydrates are fermented in the hindgut, leading to 
pH changes that cause death of bacteria and the release of lipopolysaccharide (LPS) 
across the intestinal mucosa into the circulation (Field and Jeffcott, 1989).  Following 
carbohydrate overload there is high capillary pressure, which may enhance capillary 
filtration and interstitial fluid accumulation, allowing a compartment syndrome to 
develop (Allen et al., 1990).  Following carbohydrate overload, total vascular 




reduced to one half.  The disproportionate change in pressure and flow suggests the 
use of the arteriovenous anastomoses to shunt blood through the digit.  Peroni et al. 
(2005b) described a dysfunction to venoconstriction and relaxation during the 
development of laminitis that was restricted to laminar veins, with laminar arteries 
not affected.  Constriction of the veins would increase capillary pressure, forcing 
extra blood to flow through the arteriovenous anastomoses.  It is possible that the 
vasculature of the equine hoof is biologically predisposed to venoconstriction, 
explaining why laminitis can result from such a variety of conditions (Peroni, 2005a). 
Lipopolysaccharide, when released into the blood stream, may be a factor in 
the onset of laminitis; however, experimentally induced endotoxemia does not cause 
laminitis (Pollitt, 1999).  Lipopolysaccharide alone has little effect on constriction 
and relaxation of the vascular system; therefore, it is most likely that the effects of 
LPS are mediated through the induction of vasoconstrictors.  These may include TNF, 
as Menzies-Gow et al. (2004) found a 30-fold increase in TNF concentrations at 60 
minutes after administration of LPS.  Bueno et al. (1999) and Seethanathan et al. 
(1990) also found increased TNF activity after LPS administration.  The PIC, 
interleukin-1β, had upregulated mRNA levels in the perivascular cells of capillaries in 
horses administered black walnut extract (Fontaine et al., 2001), supporting the idea 
of inflammatory changes in the hooves of horses with laminitis.  In opposition to this, 
Rodgerson et al. (2001)  did not find TNF mRNA to be upregulated in smooth muscle 
cells obtained from digital arteries exposed to LPS in vitro.  Because it appears that 
most of the vascular changes occur in the venous side of the capillary bed, it would be 




During the development of laminitis, the enzymatic remodeling process of the 
hoof may be disrupted (Pollitt, 1999).  In the normal healthy hoof, metalloproteinase-
2 (MMP2) and metalloproteinase-9 (MMP9) act catabolically to facilitate the constant 
downward growth of the hoof wall and are regulated by controlled release of specific 
MMP inhibitors.  Increased MMP production has been noted in lamellar tissues 
affected by laminitis (Johnson et al., 1998), and in other species, MMP production 
increases upon exposure to PIC (Pollitt, 1999).  Although it is unknown as to whether 
MMP upregulation directly causes disruption of the lamellar attachment, tissues 
cultured from laminitic hooves show this MMP upregulation preceding detachment of 
P3 (Pollitt, 1999).  In vitro both gram positive and gram negative bacteria induce dose 
dependent activation of MMP2 and MMP9, as well as causing separation of lamellar 
tissues in hoof explants.  This is most likely through the production of exotoxins and 
endotoxins (Mungall et al., 2000). 
 Pro-inflammatory cytokines may also control the endothelins, which are 
implicated in laminitis induction (Russell and Davenport, 1999; Battistini et al., 
1993).  Endothelin-1 expression is increased in the hoof connective tissue of laminitic 
horses (Katwa et al., 1999) and plasma concentrations are increased in horses with 
experimentally induced laminitis (Holm, 2002).  However, Menzies-Gow et al. 
(2004) did not find increased endothelin-1 concentrations after experimental LPS 
administration.  Endothelin-1 induces a concentration-dependent contraction in both 
equine arterial veins and arteries, with veins being more sensitive, suggesting that 
endothelins can selectively induce digital venoconstriction (Katz et al., 2003).  




vasodilator (Fleming and Busse, 1999; Russell and Davenport, 1999).  Vascular 
endothelial cells produce and continually release endothelin-1, in low concentrations.   
Two endothelin receptors, endothelin receptor A (ETA) and endothelin 
receptor B (ETB) are differentially expressed throughout the capillary beds of the 
hoof.  Endothelin receptor A and ETB present on the vascular smooth muscle cells 
mediate vasoconstriction, while ETB present on the vascular endothelial cells mediate 
vasodilation through nitric oxide pathways.  High levels of these receptors may be 
induced by several factors, including activated platelets, endotoxin, thrombin, PIC, 
hormones, hypoxia, and ischemia (Russell and Davenport, 1999; Battistini et al., 
1993).  However, the specific interactions between PIC and endothelins, and their 
effects on the vascular system are unknown.  While it is possible that increases in 
systemic TNF occurring during obesity may play a role in the development of chronic 
laminitis through inducing vascular changes or disrupting enzymatic remodeling, it is 
also possible that TNF action is restricted to the acute form of laminitis seen after 
exposure to endotoxin. 
Another possible explanation for the relationship of laminitis and obesity is 
that of insulin resistance, as laminitis has been directly linked to insulin resistance in 
high BCS ponies.  Kronfeld et al. (2006) found that previously laminitic ponies had 
compensated insulin resistance- a decreased insulin sensitivity with a greater 
pancreatic secretion of insulin.  When a portion of these ponies developed clinical 
laminitis, insulin levels significantly increased.  In two of the cases, insulin secretion 
began to fail, indicating a diabetic like condition.  Coffman and Colles (1983) found 




than normal ponies.  These results were also noted by Jeffcott et al. (1986), when 
comparing laminitic ponies to normal controls.  The link between insulin resistance 
and laminitis may also be due to decreased glucose uptake by the lamellar tissues 
(French and Pollitt, 2004).  Explants of horse hooves maintained in glucose solution 
did not undergo lamellar separation, whereas those maintained in saline underwent a 
lamellar separation characteristic of laminitis (Pass et al., 1998).  This provides 
evidence for the hypothesis that insulin resistance leading to decreased glucose 
uptake is a risk factor for the development of laminitis through the reduction of 
energy substrates available to the metabolically active laminae. 
Hyperlipemia/Hyperlipidemia.  During normal metabolism, fatty acids are released 
from the adipose tissue by the enzyme hormone sensitive lipase (HSL).  Hormone 
sensitive lipase activity is inhibited by insulin and glucose, but increased by glucagon, 
thus releasing fatty acids during fasting, when glycogen stores are low (Watson et al., 
1992a).  Fatty acids are primarily taken up by the liver, where they are either oxidized 
to acetyl CoA, used for gluconeogenesis, or esterified to triglycerides and stored, or 
released as very low density lipoproteins (VLDL) (Jeffcott and Field, 1985; Naylor, 
1982; Watson and Love, 1994).  In circulation, fatty acids are released from VLDL’s 
via the enzyme lipoprotein lipase (LPL) located in the capillary endothelium, and 
used for energy by adipocytes, skeletal, and cardiac cells (Watson and Love, 1994; 
Mogg and Palmer, 1995) .   
In horses, hyperlipidemia is characterized by circulating triglycerides (TGL) 
levels of 1-5 mmol/liter, while hyperlipemia is characterized by circulating TGL 




Hyperlipemia is marked by hepatic lipidosis, fat infiltration of body tissues, organ 
dysfunction, and a high mortality rate (Naylor, 1980; Watson et al., 1992a; Schotman 
and Wagenaar, 1968).  Schotman and Wagenaar (1968) found that as plasma total 
lipids increased, the percent of Shetland ponies that survived hyperlipemia decreased, 
demonstrating the lethality of this condition.   
Hyperlipemia most often occurs as a result of a disease or metabolic process 
that causes marked negative energy balance, such as food deprivation or the 
metabolic demands of pregnancy and lactation (Frank et al., 2002; Schotman and 
Wagenaar, 1968; Seifi et al., 2002).  Eighty-three to 100% of miniature horse cases 
(Mogg and Palmer, 1995), 30% of pony breeds cases (Gay, 1978; Watson, 1992), and 
100% of horse cases of hyperlipemia or hyperlipidemia are caused by a primary 
disease or metabolic problem.  Hyperlipemia is most prevalent among pony breeds 
and donkeys (Jeffcott, 1985; Watson and Love, 1992; Gilbert, 1986), with horse 
breeds rarely effected, although horses may develop hyperlipidemia.  Ponies have a 
greater propensity to release free fatty acids from adipocytes upon norepinephrine 
stimulation than do horses; however plasma clearance rates do not differ between 
sub-species (Breidenbach et al., 1999).     
 Hyperlipemia may also occur in insulin resistant animals (Jeffcott and Field, 
1985).  Insulin signaling is important for regulating the activity of HSL through 
inhibition, and LPL through activation.  In the case of insulin resistance, HSL and 
LPL may not be regulated properly, leading to over release of triglycerides (TGL) 
from the liver, and TGL accumulation in the blood (Watson and Love, 1992; 




of VLDL from the blood (Freestone, 1991b); however, others report that LPL activity 
was not decreased in hyperlipemia (Watson and Love, 1992).  Because ponies have a 
propensity to develop insulin resistance, they also have a greater risk of hyperlipemia 
(Jeffcott and Field, 1985). 
 Obesity tends to be a predisposing factor (Watson and Love, 1992; Jeffcott 
and Field, 1985; Mogg, 1995, Jeffcott, 1986), and there is incidental evidence that a 
positive correlation exists between body condition score and hyperlipemia risk 
(Forhead, 1994; Freestone, 1992; Reid and Mohammed, 1996).  Reid and Mohammed 
(1996) found that overweight donkeys were at a higher risk for developing 
hyperlipemia, and when Watson et al. (1990) compared donkeys in thin, ideal, and 
obese body condition, they found that plasma VLDL concentration correlated 
significantly with condition.  Obese animals have a greater store of fat to mobilize, 
and insulin resistance may promote lipid enzyme regulatory problems.  In a study on 
31 donkeys with naturally occurring hyperlipidemia/ hyperlipemia, Forhead et al. 
(1994) found a positive correlation between plasma insulin and TGL concentrations, 
and greater insulin concentrations in greater body condition score animals.  While 
Frank et al. (2006) found that obese insulin resistant horses had higher resting 
concentrations of VLDL, TGL, free fatty acids, and HDL- cholesterol.  Additionally, 
4 of 7 of these horses had chronic laminitis. 
 Tumor necrosis factor- α may also be involved in the onset of hyperlipemia.  
Kawakami et al. (1981) first noticed that exudate from LPS treated cells caused LPL 
suppression in vitro, and that the mediator of this effect was a heat labile protein.  




activities of acetyl CoA carboxylase and fatty acid synthetase in differentiating 
preadipocytes.  Later studies showed that this protein was TNF and also that TNF 
may mediate some of the metabolic changes that produce hyperlipidemia through its 
effects on lipid metabolism (Grunfeld and Feingold, 1991).  Circulating free fatty 
acids and glycerol levels increase following TNF administration in both rodents and 
humans, indicating that TNF has a role in inhibiting the anabolic activities of adipose 
tissue (Grunfeld et al., 1988; Feingold et al., 1987; Starnes et al., 1988).  Patton et al. 
(1986) found that following in vitro TNF exposure, adipocytes had decreased lipid 
storage and synthesis, as well as stimulated release of fatty acids from adipocytes.   
Within adipose tissue the functions of TNF include the suppression of several 
enzymes lipoprotein lipase at both the protein and gene levels (Ogawa et al., 1989; 
Kawakami et al., 1987; Zechner et al., 1988), decrease the synthesis of LPL 
(Kawakami et al., 1982; Pekala et al., 1983; Patton et al., 1986; Hauner et al., 1995), 
inhibition of both transcription factor C/EBP-α and the nuclear receptor PPAR γ (two 
masters of adipose cell differentiation), fatty acid binding protein 2, and metabolic 
enzymes such as fatty acid synthetase, acetyl CoA carboxylase, and GDPH, (Ogawa 
et al., 1989; Pekala et al., 1984; Torti et al., 1985).  Tumor necrosis factor-α may 
stimulate adipocytes to mobilize lipids through activation of hormone-sensitive lipase 
(HSL) (Ogawa et al., 1989), although Green et al. (1994) found no effect of TNF on 
HSL activity.  Tumor necrosis factor-α has also been associated with increased 
lipolysis of adipose tissue (Feingold, 1992; Green, 1994), inhibition of fat cell 
recruitment, and possibly induction of fat cell apoptosis (Coppack et al., 2001; Hube 




triglyceride synthesis (Feingold and Grunfeld, 1987; Feingold et al., 1989; Chajek-
Shaul et al., 1989) in rodents.   
Tumor necrosis factor- α administered to healthy rats resulted in increased 
hepatic weight, plasma TGL concentrations, hepatic TGL content, and fatty acid 
synthesis in the liver (Feingold, 1987).  However, the ability of TNF to induce hepatic 
fatty acid synthesis was limited to the liver, as no changes were seen in other tissues.  
On an immediate basis, TNF increases fatty acid synthesis by increasing intracellular 
levels of citrate, an allosteric activator of acetyl CoA carboxylase (Grunfeld et al., 
1988).  Long term, TNF increases levels of acetyl CoA carboxylase and fatty acid 
synthetase, and decreases levels of hepatic fatty acyl CoA.  Additionally, in obese 
adult men, LPL activity was inversely proportional to TNF expression, and with BW 
loss, LPL activity increased to 411% of initial levels (Kern, 1995).  During the 
sickness response, the normal function of TNF is to increase circulating levels of fatty 
acids for energy, and it is possible that this function is extrapolated to the disruption 
of lipid metabolism found in the metabolic syndrome. 
Dietary Effects on TNF and Metabolic Syndrome Components 
In both rodents and humans, high fat diets may result in increased TNF 
expression and release as shown by Borst and Conover (2005).  Rats fed a high fat 
diet showed significantly higher mRNA levels of the 17 Kd form of TNF in both red 
gastrocnemius muscle (2 fold elevation) and in visceral fat (54% increase) when 
compared to rats on a control diet.  However, serum levels were undetectable in both 




significantly greater TNF bioactivity in the retro-peritoneal fat pad, than rats fed a 
control 12% fat diet (Morin et al., 1997).  
Type of dietary fat may have effects on TNF concentrations, but the results of 
several studies are conflicting.  Obese men fed fish oil caplets did not experience any 
changes in TNF plasma concentrations (Jellema et al., 2004).  This result is consistent 
with those found in rodents with sucrose-induced metabolic syndrome, in which fish 
oil administration had no effect on TNF concentration (Alexander et al., 2004).  
However, in these rats, the symptoms of the metabolic syndrome were alleviated by 
the fish oil diet.  Opposing results were seen by Muurling et al. (2003), in which mice 
with preexisting insulin resistance were fed fish oil.  After 10 weeks of 3g/day of fish 
oil, the insulin resistant mice had lower TNF protein in their white adipose tissue, but 
there was no improvement in insulin sensitivity.  Mice on the same study that were 
diet restricted to 75% of ad libitum intake, but not fed fish oil, had improved insulin 
sensitivity as well as decreased TNF protein levels.  Additionally, when mice on two 
different fat diets were injected with LPS, the mice fed a fish oil diet had significantly 
lower TNF responses than mice fed a low fat diet (Sadeghi et al., 1999).  These 
results suggest that fish oil has the ability to diminish the production of TNF in vivo.  
In horses, α-linolenic acid supplementation reduces LPS-induced TNF production by 
macrophages in vitro (Morris, 1991).   
TNF concentrations in humans are increased by diets that are high in 
hydrogenated fats when compared to the polyunsaturated fat found in soybean oil, 
although saturated fat (butter) had no effect on TNF (Han et al., 2002).  Interestingly, 




comparison to a low fat diet (7% fat, ratio of polyunsaturated/saturated fats = 2.2), 
had increased TNF plasma concentrations at 3 week dietary challenge.  By week 7 
though, their TNF values had fallen below baseline (Shi et al., 2005).  It is possible 
that the initial increase was due to an acute stress response to the dietary change.  
Contrary to these results, diets high in starch and sugar, and low in fat and fiber, have 
been shown to decrease insulin sensitivity in the horse (Hoffman et al., 2003; Treiber 
et al., 2005).  The dichotomy of results may be due to the relatively low percent of fat 
in horse feeds as compared to the diets of humans or rodents.  In this case insulin 
resistance may be due to the high sugar content of the feeds as well as meal feeding, 
which contrasts to the evolutionary development of the horse as a continual grazer.  
To date no studies have been conducted on the effects of high fat diets on TNF 
production in the horse, and therefore, the interaction and effects are unknown. 
SUMMARY 
Obesity in horses is a condition sometimes accompanied by the development 
of metabolic disorders.  Not only are these metabolic disorders potentially fatal, but 
they are also expensive to treat and in the case of laminitis, extremely painful to the 
animal.  The mechanisms by which obese animals develop metabolic disorders are 
not completely understood, but it is possible that obesity induced up-regulation of 
TNF is involved.  While a complete understanding of these mechanisms is required in 
order to develop adequate treatment strategies, the prevention of disorders that result 
from obesity, through the prevention of obesity, is also an important management 
tactic.  This includes the ability to monitor equine condition on a continual basis in 




expense, easily applied system for measuring adiposity, and therein lays its usefulness 
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ABSTRACT 
Subcutaneous fat deposition is an indicator of energy balance in horses, and is 
therefore useful in making feeding management decisions.  The most commonly used 
body condition scoring (BCS) system was developed in light breed mares and assigns 
a subjective score of fat accretion at six different body areas.  While the system is 
useful, its drawbacks include that it may not be applicable to all horse breeds or 
genders and that the written definitions of fat accretion are non specific and often 
difficult to use.  The main objective of this study was to examine the usefulness of the 
Henneke BCS system for Thoroughbred (TB) geldings through examining effects of 
weight gain and diet on body area fat accretion in these horses.  A second goal of this 
study was to use the information gained to modify the Henneke BCS system, such 
that it is specific to TB geldings.  In this study, fifteen mature TB geldings were fed 
for weight gain over a nine month period on either a high in starch and sugar (HS) 




area BCS on a monthly basis by two experienced judges using the Henneke BCS 
system.  Throughout the study body area fat accretion characteristics were recorded.  
Differences between judge scores ranged from 0.10 to 0.81 across all time periods 
and body areas.  Neither judge scored consistently higher than the other.  Across the 
study period, neck scores averaged greater than those of withers and during months 
two through eight, neck scores averaged greater than loin scores.  Out of 62 possible 
combinations of body areas, 37 were able to predict the mean BCS with a 95% 
prediction interval of ≤ 0.5 scores, including six 5-body area equations, eleven 4-body 
area equations, and seventeen 3-body area equations.  The results of this study 
suggest that a more accurate BCS system for Thoroughbreds should be developed and 
that a fewer subset of body areas may be used to predict BCS. 
Keywords:  body condition score, body fat, horse, weight gain 
INTRODUCTION 
 Body condition scoring is a subjective method of estimating subcutaneous fat 
cover in many livestock species, and is one of the most widely used indices of energy 
balance in equine feeding management.  Body condition scores (BCS) are often used 
as either a statistical blocking factor or response factor in nutrition, physiology, and 
reproductive studies.  Therefore, the ability to assess temporal changes in fat 
deposition, hence energy balance, is useful not only to researchers, but also to 
veterinarians and horse owners.  The Henneke (1983) BCS system was developed in 
pre-parturient Quarter horse mares with fat cover scored on a scale of 1 (thin) to 9 
(fat) by physical palpation and visual assessment of six discrete body areas; neck, 




system and has been applied to all breeds, ages, and genders of horses.  This has been 
done without determining if the system accurately describes body area fat accretion in 
these different classes of horses, or if all classes of horses accrue subcutaneous fat in 
the same locations.    
Diet may also affect body area adipose gain as a result of the possible 
differences in efficiency of fat storage when the proportion of fat to carbohydrate 
changes.  High fat diets have been used to induce obesity in rodents (Borst et al., 
2005; West and York, 1998), however, in horses it is unknown whether a high fat diet 
will increase either overall BCS gain or individual body area rates of gain. 
The main objective of this study was to evaluate the usefulness of the 
Henneke BCS system for Thoroughbred (TB) geldings, and also to determine whether 
modifications to the system are needed for that specific population of horses. Two 
additional goals of the study were to determine if 1) dietary energy source affected fat 
accretion rates, and 2) if a smaller subset of body areas could be used to accurately 
predict the overall mean BCS using the Henneke BCS system. 
MATERIALS AND METHODS 
The study was conducted over a period of 10 months, from July 2005 to May 2006 at 
the University of Maryland’s Equine Research Unit, in Ellicott City, MD and was 
approved by the University of Maryland’s Institutional Animal Care and Use 
Committee.  It was conducted in accordance with a companion study investigating the 





Fifteen mature Thoroughbred geldings (initial BW range 466 to 596 kg, initial 
BCS range 3.8 to 5.1; initial age range 5 to 15 y) were used in this study.  All horses 
received routine veterinary health care including vaccinations- Eastern, Western, and 
Venezuelan encephalitis, Rhinopneumonitis, Influenza, Tetanus (Prestige V + VEE, 
Intervet, Millsboro, DE) Potomac horse fever and West Nile (Potomac Guard and 
West Nile Innovator, Fort Dodge Animal Health, Overland Park, KS), dental care, 
and a broad spectrum dewormer (Zimecterin Gold Ivermectin/Praziquantel, Merial, 
Duluth, GA) before the start of the study and throughout the study as needed.  Horses 
were housed in individual (3.6 m2) box stalls with rubber mats and wood pellet litter 
(Woody Pet Products, Surrey, BC, Canada).  Horses were weighed on a livestock 
platform scale (Central Carolina Scale, Sanford, NC) prior to the start of the study, 
and then weekly thereafter.  Horses were housed in the barn for three weeks prior to 
the start of the study to allow for acclimation the experimental conditions. 
Diets 
During the three week acclimation period, horses received mixed grass/alfalfa 
hay and a commercially available concentrate (Legends 10, Southern States 
Cooperative, Richmond, VA) fed to meet their daily DE requirement for maintenance 
(NRC, 1989).  After the acclimation period horses were randomly assigned to one of 
two experimental concentrates designed to be isonitrogenous and isoenergetic, but 
differing in energy source, either high in starch and sugar (HS; n = 9) or fiber and fat 
(HF; n = 6) (Table 1).  Horses were transitioned onto the treatment feeds over a 




concentrate at a ratio of 60% DE from hay and 40% DE from concentrate.  Hay was 
fed in a wooden box mounted on the floor in the corner and grain was fed from 
canvas feed bags (Country Supply, Louisiana, MO).  Total daily intake of hay and 
concentrate was split into two meals fed at 0800 and 1900.  Hay was offered first, 
with concentrate offered immediately following.  Refusals of concentrate were 
collected and weighed after each feeding.  Refusals of hay were collected and 
weighed on a daily basis, before the 0800 feeding.  Intake of hay and concentrate was 
recorded daily.   
Hay samples were obtained by random core sampling from no less than 25% 
of the hay used in the study (n = 14).  Concentrate samples were obtained by random 
grab sampling (n = 8) on a monthly basis.  Hay and concentrate were submitted for 
nutrient analysis to a commercial laboratory (Table 1) (Dairy One, Ithaca, NY).  
Access to fresh clean water and salt blocks containing only sodium chloride were 
available at all times.   
Weight Gain   
Horses were fed at maintenance for four weeks to allow for acclimation to the 
treatment diets, and then feeds were increased to weight gain intake levels over a 
period of one week.  Horses were fed for a targeted weight gain of 23 kg per three 
weeks, which was previously shown to result in a gain of one BCS score (Heusner, 
1993).  In order to achieve the targeted weight gain, hay and concentrate was fed to 
provide each horse with an additional 20 Mcal DE above their daily DE requirement 
for maintenance.  Horses were fed for weight gain over a period of eight months, 




seven Mcal DE was offered daily to each horse via concentrate at 1400 h in order to 
encourage an increase in ADG.   
Exercise 
Horses were exercised at a walk (1.5m/s) for 35 min twice daily on a six horse 
automated equine exerciser (Priefert, Mt. Pleasant, TX).  Horses were permanently 
assigned to one of three exercise groups, which were exercised in a random order, 
between 0900-1100 and 1630-1830.  The companion study included a two week 
minimal exercise period following the weight gain period of the study; however data 
from that period was not used in this study. 
Body Condition Scoring 
Body condition scores were assessed monthly by two independent judges 
using a BCS system with a nine point scale (Henneke et al., 1983).  Judges were 
selected based on their equine expertise and knowledge of the BCS system.  Each 
judge conducted their body condition scoring independently of each other, but scores 
were obtained within 24 h of each other.  On three occasions, scores could not be 
obtained by both judges, and in this case, body condition scoring by both judges was 
conducted the following week.  Each of the six body areas (neck, withers, shoulders, 
ribs, loin, and tailhead) were assessed using both physical palpation (e.g., gently 
pressing or pinching fat along the designated body area) and visual appraisal in order 
to determine the amount of fat present.  Body areas were scored, and an average of 
the six was used as a mean BCS for each horse at each assessment period.  




the study, which included both visual and physical observations of fat fill, tone, and 
feel, to be used for describing subcutaneous fat accumulation in TB geldings.   
Statistical Analysis 
Monthly body weight data were analyzed by repeated measures ANOVA 
using the mixed models procedure of SAS (v. 9.1 SAS Institute Inc., Cary, NC) in 
order to determine the effects of month and diet.  Monthly BCS data were analyzed 
by repeated measures ANOVA in order to determine the effects of month and diet.  
Monthly DE intakes were analyzed at each month by ANOVA in order to determine 
the effects of diet. 
Judge precision.  In order to analyze the precision between the two judges, data were 
analyzed using aggregate analysis according to methods adapted from those described 
previously (Bland and Altman, 1986), where the differences between judges’ scores 
(DIFF) of each body area served as the dependent variable.  The effects of diet, body 
part, and month on DIFF were analyzed by repeated measures ANOVA.  Significance 
was established from least squares means, which tested the mean DIFF as being 
significantly different from zero.  A α level of P < 0.05 was used for the 
determination of significance.   
Agreement of body area scores.  The effects of time and diet on body area scores 
were determined using repeated measures ANOVA.  A α level of P < 0.05 was used 
for the determination of significance. 
Prediction of BCS.  To determine whether a smaller subset of body areas could 
accurately predict the overall BCS, prediction equations were generated.  For this 




run individually through a mixed model ANOVA, with mean BCS as the dependent 
variable and the specific combination of body areas to be tested as the predictor 
variables.  Influence diagnostics were used to remove one horse at a time from each 
equation through the use of influence statistics.  The predicted residual sums of 
squares (PRESS) statistic represents the observed (actual mean BCS) minus predicted 
(group mean BCS) when one observation is deleted, which in this case is the mean 
BCS for an individual horse.  The PRESS statistics were summed (sPRESS) and used 
to determine the prediction r2 using the equation [(Total sums of squares- Month 
sums of squares) – (sPRESS] / [Total sums of squares - month sums of squares].  
Prediction intervals were calculated from the confidence intervals by the equation (√ 
(sPRESS/ horse sums of squares))*confidence interval.  Thus prediction equations 
were developed on all horses minus one, and then asked to predict the one horse that 
was deleted.  Weighted coefficients for each prediction equation were determined 
using estimate statements.   
RESULTS 
Average monthly digestible energy (DE) intakes were similar between dietary 
groups and shown in Table 2.  Average BW prior to the initiation of and at the end of 
weight gain was 519 ± 12 kg and 608 ± 12 kg, respectively.  Weight gain over the 
course of the study resulted in an average increase in BCS from 4.3 ± 0.1 to 6.9 ± 0.1.  
There was no main effect of diet on either mean BW or BCS, therefore monthly 
means were averaged across diets and presented in Figure 1.   
Judge precision was not different between dietary groups, however there was 




Judges scored differently at 52% of the assessments with differences ranging from 
0.28 to 0.81 scores (P < 0.05).  Neither judge scored consistently either higher or 
lower than the other.   
Figure 2 shows the interaction between body area and diet (P = 0.015) for 
body area scores.  Horses on the HF diet had higher scores at the neck (P = 0.030) 
and withers (P = 0.060).  Figure 3 shows the interaction between time and body area 
(P < 0.001) for body area scores.  Neck scored higher than withers and loin from Sep 
through Apr, and neck also scored higher than loin from Oct through Apr.    
There were 62 possible combinations of body areas that were evaluated for 
their ability to predict the mean BCS (Table 4).  Of these, 37 equations had a 95% 
prediction interval of ≤ 0.50 scores, which ranged from 0.16 to 0.50.  Characteristics 
of fat accretion observed during this study are described for each body area (Table 4). 
DISCUSSION 
 The Henneke BCS system was developed on pre-parturient Quarter Horse 
mares, and has since been extrapolated to all breeds and genders without determining 
its suitability for these other classes of horses, such as its use in ponies (Freestone et 
al., 1992) and draft horses (Potter et al., 1987).  Body condition scoring systems need 
to demonstrate three specific qualifications in order to be valid: repeatability, 
reproducibility, and predictability (Burkholder, 2000; Evans, 1987).  Repeatability is 
one test of a BCS system’s precision, such that one judge repeatedly assigns the same 
score to one animal.  Reproducibility is another test of a BCS system’s precision, 
such that one or more judges assign the same score to the same animal, and is the 




accurately reflect the fat cover of an animal.  The predictability of the Henneke BCS 
system was determined by Henneke et al. (1983) using body fat equations developed 
by Westervelt et al. (1976).   
The main objective of this study was to examine the usefulness of the 
Henneke BCS system for TB geldings as part of a companion study investigating the 
effects of weight gain on insulin sensitivity.  Precision of the Henneke BCS system 
was analyzed by comparing two judge’s scores to each other.  Body condition scores 
are defined at the whole-score level, yet half scores may be used, and because of this, 
it was our goal to determine if the two judges were able to agree with each other 
within a half score or 0.5.  The fact that two judges scored differently from each other 
more than half of the time indicates the subjective nature of the BCS scoring system.  
Reasons that the judges may not have been able to more consistently assign the same 
score to body areas include 1) the descriptions of fat accretion within each body area 
score may be too ambiguous too allow for objective interpretation, and 2) because the 
system relies on visual and physical appraisal, there is an inherent degree of user bias 
involved in the assigning of scores.  Both factors are inevitably involved in the error 
associated with BCS.  The purpose of a BCS system is to describe an amount of 
subcutaneous fat by assigning a discrete number, but inherently a human’s ability to 
accurately quantify fat accretion is limited.  This has impacts on both the ability to 
develop a system with explicit BCS descriptions, as well as the ability of a user to 
interpret BCS descriptions in an unambiguous manner.   
While score disagreement could be expected at all body areas, the unequal 




body areas most disagreed upon are not specific enough to allow for score 
differentiation.  It is also possible that there are extraneous factors specific to those 
body areas, such as TB conformation, that affected unbiased score assignment in this 
BCS range.  That the two judges used in this study were not consistently able to 
assign the same score to all body areas, even with their substantial prior experience 
with body condition scoring suggests that between the score range of a four to seven, 
the score characteristics of these body areas require refinement for use in for TB 
geldings.   
Assessing the usefulness of the Henneke BCS system for TB geldings 
included determining whether body area scores need adjustment in relation to each 
other.  This was done with the goal of determining if the TB geldings on this study 
were being assigned the same scores to each body area during each assessment.  
There were several differences in scores assigned to body areas during all months of 
the study.  Neck scores were consistently higher than withers and were also higher 
than loin scores during seven of the eight months.  Although differences were 
expected, the consistency of the neck scoring being greater than withers and loin may 
indicate that TB’s put fat down on their neck earlier during weight gain than the loin 
or withers.  It could also indicate that this area is easier to score through allowing 
judges to more readily differentiate when a horse had achieved a higher score at the 
neck than at the other two body areas.  Neck also scored greater than shoulders, ribs, 
or tailhead, albeit inconsistently throughout the study, but only at three time points 
was the neck greater than all three.  Additionally at most of the monthly assessments 




each other, suggesting that the Henneke system descriptions of these three body areas 
for those levels of fat are adequate.  The overall results of this analysis suggest that 
between the BCS range of four to seven, the fat accretion characteristics of each score 
need a minor adjustment in order to be specific to the way that TB geldings lay down 
fat.  This includes adjusting the neck score such that scores assigned to the neck are 
more likely to reflect the scores given to the other body areas.  For these reasons we 
adjusted the neck score and developed more specific descriptions of both the 
anatomical locations of fat accretion and the characteristics of fat accretion scores for 
each body area between a BCS of four and seven.  We suggest that these be tested on 
a separate population of TB geldings and used in the future.   
The second goal of this study was to determine if dietary energy source might 
effect fat accretion at different body areas.  The diets were designed to be 
isoenergetic, but differ in percent fat, ADF, NDF and NSC.  Concentrates were 
formulated based on theoretical DE values of feed stuffs as calculated from Harris 
and Kronfeld (2003).  The “by difference method” of determining DE values of feeds 
may underestimate the actual DE value of high fiber feeds due to the energy available 
from the fermentation products.  In this study horses on the HF diet scored higher at 
the neck and withers than horses on the HS diet.  However, while this may suggest 
that dietary energy source had an effect on body area fat accretion, the effect was not 
great enough to cause a main effect on the mean BCS.  Previous studies also reported 
no difference in mean BCS for horses on either a high in fat and fiber diet or a high in 
starch and sugar diet (Hoffman et al., 2003; Williams et al., 2001).  This may mean 




high fat and fiber diets than high starch and sugar diets, and may have implications 
for feeding strategies. 
The third goal of this study was to identify one or more equations consisting 
of a smaller subset of body areas that would accurately predict the mean BCS instead 
of using all 6 body areas identified by Henneke et al. (1983).  There are several 
benefits to using fewer body areas, including less time required, less education and 
practice required for inexperienced users to become proficient, and the ability to 
exclude body areas that are confounded by conformation.  The use of prediction 
equations allows for the equations developed on these study horses to be extrapolated 
to use in other TB geldings.  Additionally, weighted coefficients for each body area in 
each equation were reported, and allowed for determination of body areas that 
continually carried lesser or more weight than other body areas.  Within the equations 
that used five body areas, the loin was weighted less, on average than all other body 
areas, followed by the neck and then the withers, while shoulders were consistently 
weighted higher than all other body areas. 
The analyses used in this study helped us to determine that of the six body 
areas, withers and loin tended to consistently score lower than the others.  These may 
be in part due to conformational differences between breeds, as well as within a breed 
(Weller et al., 2006).  Many TB tend to have prominent, well defined withers, 
however there is a great deal of variation in the population (Anderson, 2004).  It is 
possible that differences in wither conformation complicate the process of qualifying 
the amount of fat present.  Secondly, the fit of equipment such as the saddle places 




un-saddled horse (Winkelmayr et al., 2006) and this may have long term effects on 
wither conformation.  Another factor is that of fitness level, as conditioning horses to 
carry weight increases wither height (O’Connor et al., 2002) and this may also have a 
confounding effect on score.  Therefore the withers score may confound mean BCS 
results when comparing horses to each other when horses significantly differ in their 
wither conformation.  Interestingly, the body area with the lowest precision was the 
withers, further evidence for the possible confounding tendency of this body area.   
The loin area in the TB breed may also be difficult to accurately score based 
on conformational and muscular differences.  The extent to which Thoroughbreds and 
Quarter Horses are asked to perform, and the level of athletic difficulty may change 
the musculature across the back (Eto et al., 2003; Yamano et al., 2002).  This in turn 
may change the appearance of fat deposition across the loin area, based on the 
muscles filling in beneath the subcutaneous fat (Graham -Thiers and Kronfeld, 2005).  
Gentry et al. (2002) also found that the loin area was least correlated to percent body 
fat gain in mares fed for weight gain.  During that study, fat thickness across the loin 
showed little change even as mares gained condition from a BCS of six to nine.     
This study shows that an accurate BCS can be derived using several 
combinations of fewer body areas.  Although the goal of this research was to 
determine a best fit equation, the presence of multiple equations meeting the defined 
criteria made this difficult.  The authors support the removal of the withers area from 
the BCS equation due to the possible effect of conformational differences on score 
assignment, as supported by the fact that it was the least agreed on body area.  




remaining five body areas.  Possible recommendations include using the shoulders, 
ribs and tailhead areas, as they tended to agree most often with each other as well as 
receiving the highest weight coefficients within the equations utilizing five body 
areas.  One of the goals of this analysis was to identify the equation with the fewest 
body areas and lowest prediction interval; however, whereas many of the weighted 
coefficients for the four body area equations were relatively equal, very few of the 
three body area equations have near equal weighted coefficients.  Therefore it is 
difficult to recommend one equation over the others.  Ideally, a few selected 
equations, such as those including shoulders, ribs, and tailhead should be tested using 
a separate population of horses 
IMPLICATIONS 
 Although horses accrue subcutaneous fat at six different areas of their body, 
fewer body areas may be used to accurately predict mean BCS.  More specific 
descriptions of fat accretion characteristics have been reported and require testing to 
delineate their usefulness for more accurately predicting BCS in TB’s.   
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Table 1.  Nutrient composition of a mixed grass/alfalfa hay (Hay) and either a 
concentrate high in starch and sugar (HS) or high in fiber and fat (HF) fed to horses1, 2 
            
Nutrient Hay Hay SEM HS HF 
Pooled 
SEM3 P-value4 
CP, % 14.4 1.0 10.0 10.1 0.6   0.965 
ADF, % 34.2 0.4   8.0 21.7 1.3 <0.001 
NDF, % 53.9 0.1 17.0 32.8 1.3 <0.001 
NSC5, % 14.2 0.1 56.7 20.1 1.4 <0.001 
Fat, %   3.1 0.8   4.3 17.2 0.9 <0.001 
Ash, %   7.0   0.02   4.6  7.4 0.5   0.001 
Ca, %   0.8       1.9   0.7  1.2 0.1   0.010 
P, %   0.3 1.5   0.3  0.3   0.03   0.041 
DE, Mcal/kg   1.0  0.02   3.6  2.9   0.03 <0.001 
DE, Mcal/kg6     3.6  3.5   
1
 DM basis as analyzed by Dairy One (Ithaca, NY)      
2 n = 15 for Hay; n = 9 for HS; n = 6 for HF 
3 SEM pooled for HS and HF concentrates 
4 Significance of differences between HS and HF concentrates 
5 Non-structural carbohydrates 
6 Theoretical DE value calculated based on the feed formulation, as proposed by 











Table 2.  Digestible energy (DE) intakes of horses fed to gain weight over eight 
months on a mixed grass/alfalfa hay and either a concentrate high in starch and sugar 
(HS) or high in fat and fiber (HF) 1, 2 
    
Month HS (n=8)3 HF (n=6) 
P-
value 
 --- Mcal/d---  
Aug 18.0 ± 0.5 18.2 ± 0.5 0.735 
Sep 35.8 ± 0.5 34.8 ± 0.5 0.946 
Oct 33.4 ± 1.0 32.1 ± 1.1 0.414 
Nov 35.1 ± 1.7 32.7 ± 1.8 0.349 
Dec 39.2 ± 2.0 37.5 ± 2.2 0.576 
Jan 33.0 ± 1.6 28.3 ± 1.7 0.066 
Feb 34.6 ± 1.9 31.5 ± 2.0 0.286 
Mar 36.5 ± 2.7 32.7 ± 2.9 0.347 
Apr 36.0 ± 2.1 30.5 ± 2.2 0.091 
1 DE calculated based on formulations proposed by Harris and Kronfeld (2003)   
2 DE intakes are represented as means ± SEM 

























Table 3.  Precision of body condition scores (BCS) assigned to six body areas by two 
judges over the 8 mo study 1 
          
Month 
Body 
Area Precision2  SE 
P - 
value 
Aug Neck    -0.18 0.13 0.156 
 Withers 0.00 0.13 1.000 
 Shoulders -0.37 0.13 0.003 
 Ribs -0.26 0.13 0.039 
 Loin -0.17 0.13 0.191 
 Tailhead -0.13 0.13 0.326 
Sep Neck 0.08 0.13 0.513 
 Withers 0.38 0.13 0.003 
 Shoulders 0.12 0.13 0.326 
 Ribs 0.18 0.13 0.156 
 Loin 0.06 0.13 0.663 
 Tailhead 0.04 0.13 0.743 
Oct Neck 0.21 0.13 0.102 
 Withers 0.85 0.13 <0.001 
 Shoulders 0.47 0.13 <0.001 
 Ribs 0.57 0.13 <0.001 
 Loin 0.31 0.13 0.017 
 Tailhead 0.38 0.13 0.003 
Nov Neck -0.47 0.13 <0.001 
 Withers 0.28 0.13 0.029 
 Shoulders -0.07 0.13 0.585 
 Ribs -0.08 0.13 0.513 
 Loin 0.06 0.13 0.663 
 Tailhead -0.01 0.13 0.913 
 1 Scores assigned using the method of Henneke et al. (1983) 











Table 3 continued.  Precision of body condition scores (BCS) assigned to six body 
areas by two judges over the 8 mo study 1 
          
Month 
Body 
Area Precision2  SE 
P - 
value 
Dec Neck 0.13 0.13 0.039 
 Withers 0.24 0.13 0.064 
 Shoulders 0.07 0.13 0.585 
 Ribs 0.14 0.13 0.275 
 Loin 0.13 0.13 0.326 
 Tailhead 0.06 0.13 0.663 
Jan Neck -0.29 0.13 0.022 
 Withers 0.56 0.13 <0.001 
 Shoulders 0.17 0.13 0.191 
 Ribs -0.19 0.13 0.127 
 Loin 0.15 0.13 0.230 
 Tailhead 0.00 0.13 1.000 
Feb Neck -0.01 0.13 0.913 
 Withers 0.56 0.13 0.050 
 Shoulders 0.06 0.13 0.662 
 Ribs 0.18 0.13 0.156 
 Loin 0.32 0.13 0.012 
 Tailhead 0.17 0.13 0.191 
Mar Neck -0.38 0.13 0.003 
 Withers -0.32 0.13 0.012 
 Shoulders -0.31 0.13 0.017 
 Ribs -0.81 0.13 <0.001 
 Loin -0.31 0.13 0.017 
 Tailhead -0.51 0.13 <0.001 
Apr Neck -0.49 0.13 <0.001 
 Withers -0.07 0.13 0.585 
 Shoulders -0.43 0.13 <0.001 
 Ribs -0.57 0.13 <0.001 
 Loin 0.54 0.13 <0.001 
 Tailhead -0.18 0.13 0.156 
 1 Scores assigned using the method of Henneke et al. (1983) 





Table 4.  Weighted body condition score prediction equations, 95% prediction 
intervals, and prediction r² for all possible combinations of body areas1 
    
Body 






NWRLT 0.20*N + 0.21*W + 0.23*R + 0.18*L + 0.18*T 0.16 0.99 
NWSLT 0.17*N + 0.19*W 0.24*S + 0.21*L + 0.19*T 0.17 0.99 
NWSRL 0.20*N + 0.17*W + 0.19*S + 0.21*R + 0.23*L 0.19 0.98 
NSRLT 0.21*N + 0.25*S + 0.21*R + 0.16*L + 0.17*T 0.23 0.98 
NWSRT 0.15*N + 0.17*W + 0.18*S + 0.25*R + 0.26*T 0.24 0.98 
WSRLT 0.23*W + 0.24*S + 0.16*R + 0.14*L + 0.22*T 0.30 0.97 
NWRL  0.24*N + 0.22*W + 0.29*R + 0.25*L 0.27 0.98 
NWRT 0.18*N + 0.21*W + 0.33*R + 0.28*T 0.29 0.95 
NWSL 0.20*N + 0.20W + 0.30*S + 0.30*L 0.30 0.97 
NSRL  0.24*N + 0.28*S + 0.25*R + 0.23*L 0.30 0.97 
NWLT 0.22*N + 0.29*W + 0.25*L + 0.24*T 0.30 0.97 
NSLT 0.21*N + 0.37*S + 0.21*L + 0.21*T 0.31 0.97 
NSRT 0.19*N + 0.27*S + 0.28*R + 0.26*T 0.31 0.97 
WSLT .025*W + 0.31*S + 0.19*L + 0.25*T 0.32 0.97 
WSRT 0.21*W + 0.25*S + 0.24*R + 0.30*T 0.32 0.97 
NRLT 0.28*N + 0.35*R + 0.17*L + 0.20*T 0.35 0.97 
WRLT 0.31*W + 0.27*R + 0.15*L + 0.27*T 0.36 0.97 
NWST 0.14*N + 0.19*W + 0.32*S + 0.35*T 0.36 0.97 
WSRL  0.24*W + 0.30*S + 0.22*R + 0.24*L 0.40 0.97 
SRLT 0.40*S + 0.22*R + 0.13*L + 0.25*T 0.41 0.96 
NWSR 0.21*N + 0.15*W + 0.26*S + 0.38*R 0.42 0.96 
NSL 0.26*N + 0.43*S + 0.31*L 0.39 0.97 
WRT 0.30*W + 0.35*R + 0.35*T 0.40 0.97 
WST 0.24*W + 0.38*S + 0.38*T 0.41 0.97 
NRL 0.34*N + 0.40*R + 0.26*L 0.41 0.96 
NRT 0.27*N + 0.43*R + 0.30*T 0.42 0.96 
SRT 0.40*S + 0.28*R + 0.32*T 0.43 0.96 
NWL 0.28*N + 0.33*W + 0.39*L 0.43 0.96 
NST 0.19*N + 0.45*S + 0.36*T 0.45 0.96 
NSR 0.25*N + 0.33*S + 0.42*R 0.46 0.96 
WSL 0.28*W + 0.41*S + 0.31*L 0.46 0.96 




Table 4 continued.  Weighted body condition score prediction equations, 95% 
prediction intervals, and prediction r² for all possible combinations of body areas 
    
Body 






NWR 0.26*N + 0.23*W + 0.51*R 0.48 0.96 
WLT 0.41*W + 0.24*L + 0.35*T 0.48 0.96 
SLT 0.52*S + 0.18*L + 0.30*T 0.48 0.86 
NWT 0.20*N + 0.34*W + 0.46*T 0.48 0.85 
WRL 0.36* W + 0.37*R + 0.27*L 0.49 0.96 
WSR 0.23*W + 0.37*S + 0.40*R 0.50 0.96 
SRL 0.48*S + 0.29*R + 0.23*L 0.52 0.84 
NLT 0.37*N + 0.31*L + 0.32*T 0.55 0.81 
RLT 0.50*R + 0.12*L + 0.38*T 0.61 0.76 
NWS 0.23*N + 0.22*W + 0.55*S 0.62 0.76 
ST 0.58*S + 0.42*T 0.52 0.83 
WT 0.42*W + 0.58*T 0.56 0.80 
NR 0.38*N + 0.62*R 0.57 0.80 
SR 0.54*S + 0.46*R 0.59 0.78 
SL  0.68*S + 0.32*L 0.60 0.77 
RT  0.55*R + 0.45*T 0.60 0.77 
WR 0.38*W + 0.62*R 0.61 0.77 
WL  0.53*W + 0.47*L 0.67 0.72 
NL  0.49*N + 0.51*L 0.67 0.72 
WS 0.30*W + 0.70*S 0.68 0.71 
NS 0.29*N + 0.71*S 0.69 0.71 
NT 0.39*N + 0.61*T 0.72 0.67 
RL  0.71*R + 0.29*L 0.77 0.63 
NW 0.44*N + 0.56*W 0.90 0.50 
LT 0.34*L + 0.66*T 1.02 0.49 
S S 0.79 0.61 
R R 0.82 0.57 
W W 0.89 0.50 
L L 0.99 0.38 
N N 1.27 0.00 
T T 1.35 -0.14 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1.   Body condition scores (BCS) and body weight (BW) of horses fed for 
weight gain on a mixed grass/alfalfa hay and either a concentrate high in starch and 
sugar or high in fat and fiber.  Monthly means are averaged across diets and 
represented as mean ± SE.  a,b,c,d, e, f, g Means with unlike superscripts within either 



























Figure 2.  Differences in body area body condition score (BCS) for horses fed mixed 
grass/alfalfa hay and either a concentrate high in starch and sugar (HS) or high in fat 
and fiber (HF).  Data averaged for two judges and represented as the mean ± SE.  
a,b,c,d,e Means with unlike superscripts differ (P < 0.05). *Dietary groups differ (P < 
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 Obesity in horses is associated with an increased risk for the development of 
metabolic disorders such as insulin resistance, hyperlipemia, and laminitis.  As yet 
there is no defined upper “safe” limit of adiposity; however in other species 
increasing adiposity has been associated with an increased level of systemic 
inflammation, as indicated by circulating concentrations of tumor necrosis factor- α.  
This increase in inflammation may preclude the development of the metabolic 
diseases of obesity seen in humans.  The objective of this study was to assess whether 
the level of fatness, type of diet, and/or a cessation of exercise would affect the 
inflammatory state of the horse as measured by serum TNF concentrations.  Fifteen 
mature Thoroughbred (TB) geldings with an average initial body condition score 
(BCS) of 4.4 were fed for weight gain over eight months on a diet of hay plus a 
concentrate that was either high in starch and sugar (HS) or high in fat and fiber (HF).  




determination of serum TNF.  For two weeks following the weight gain period of the 
study, normal daily exercise of 1.5 m/s for 35 min twice daily was restricted.  There 
was no effect of diet on serum TNF concentrations.  Horses at a BCS of four had 
higher TNF concentrations than horses at a BCS of seven; however, TNF was not 
different in horses at a BCS of five, six, or seven.  There was a trend for an increase 
of TNF (P = 0.075) when horses were not exercised.  Horses at a BCS less than five 
are at a higher risk for inflammation than those between a five and seven.  
Keywords:  diet, condition, fat, horse, TNF, weight gain 
INTRODUCTION 
 Obesity is the result of long term positive caloric balance and in horses is 
often the result of a lack of knowledge on the owners’ part about proper feed types 
and amounts, and exercise management (Johnson, 2002).  As yet, there is no defined 
upper “safe” limit of adiposity in horses; however it is imperative that this be 
determined because obese animals are at a greater risk for the development of life 
threatening metabolic conditions such as laminitis (Jeffcott et al., 1986; Fontaine et 
al., 2001) and hyperlipemia (Jeffcott et al., 1985; Hughes, 2004).  Adiposity has been 
positively correlated with increasing systemic concentrations of pro-inflammatory 
cytokines such as TNF in humans (Hotamisligil et al., 1995) and horses (Vick et al., 
2007) which are produced by the accumulating adipose tissue.  In humans, an 
increase in TNF has been associated with low grade inflammation (Sethi et al., 1999) 
that precludes development of the metabolic diseases of obesity, such as diabetes type 




also appears to be at risk for metabolic conditions (Johnson et al., 2002; Kronfeld et 
al., 2006; Treiber et al., 2006), a similar mechanism of TNF action may exist.   
Diet and exercise may also affect the relationship between obesity and TNF 
secretion from adipose tissue.  The HF diet was supplemented with corn oil, a feed 
component that is commonly added to horse feeds to aid in weight gain or to increase 
the caloric density of feeds for equine athletes.  Corn oil has a high ratio of n-6: n-3 
fatty acids, which has been found to increase inflammation in obese rats (Morin et al, 
1997; Alexander et al., 2004).  Alternatively, regular exercise decreased the risk of 
metabolic diseases in obese humans (Ziccardi et al., 2006) and horses (28-34% body 
fat, Powell et al., 2002), but it was not known whether it occurred as a result of a 
change in inflammatory status or another mechanism.   
The objectives of this study were to assess levels of inflammation in 
Thoroughbred geldings as they gained weight and when fed diets differing in energy 
source.  Another objective of this study was to evaluate whether a short term 
restriction in daily exercise would influence inflammatory state in fleshy horses. 
MATERIALS AND METHODS 
The study was conducted over a period of 10 months, from July 2005 to May 2006 at 
the University of Maryland’s Equine Research Unit, in Ellicott City, MD and was 
approved by the University of Maryland’s Institutional Animal Care and Use 
Committee.  It was conducted in accordance with a companion study investigating the 





Fifteen mature Thoroughbred geldings (initial BW range 466 to 596 kg, initial 
BCS range 3.8 to 5.1; initial age range 5 to 15 y) were used in this study.  All horses 
received routine veterinary health care including vaccinations- Eastern, Western, and 
Venezuelan encephalitis, Rhinopneumonitis, Influenza, Tetanus (Prestige V + VEE, 
Intervet, Millsboro, DE) Potomac horse fever and West Nile (Potomac Guard and 
West Nile Innovator, Fort Dodge Animal Health, Overland Park, KS), dental care, 
and a broad spectrum dewormer (Zimecterin Gold Ivermectin/Praziquantel, Merial, 
Duluth, GA) before the start of the study and throughout the study as needed.  Horses 
were housed in individual (3.6 m2) box stalls with rubber mats and wood pellet litter 
(Woody Pet Products, Surrey, BC, Canada).  Horses were weighed on a livestock 
platform scale (Central Carolina Scale, Sanford, NC) prior to the start of the study, 
and then weekly thereafter.  Horses were housed in the barn for three weeks prior to 
the start of the study to allow for acclimation the experimental conditions. 
Diets 
During the three week acclimation period, horses received mixed grass/alfalfa 
hay and a commercially available concentrate (Legends 10, Southern States 
Cooperative, Richmond, VA) fed to meet their daily DE requirement for maintenance 
(NRC, 1989).  After the acclimation period horses were randomly assigned to one of 
two experimental concentrates designed to be isonitrogenous and isoenergetic, but 
differing in energy source, either high in starch and sugar (HS; n = 9) or fiber and fat 
(HF; n = 6) (Table 1).  Horses were transitioned onto the treatment feeds over a 




concentrate at a ratio of 60% DE from hay and 40% DE from concentrate.  Hay was 
fed in a wooden box mounted on the floor in the corner and grain was fed from 
canvas feed bags (Country Supply, Louisiana, MO).  Total daily intake of hay and 
concentrate was split into two meals fed at 0800 and 1900.  Hay was offered first, 
with concentrate offered immediately following.  Refusals of concentrate were 
collected and weighed after each feeding.  Refusals of hay were collected and 
weighed on a daily basis, before the 0800 feeding.  Intake of hay and concentrate was 
recorded daily.   
Hay samples were obtained by random core sampling from no less than 25% 
of the hay used in the study (n = 14).  Concentrate samples were obtained by random 
grab sampling (n = 8) on a monthly basis.  Hay and concentrate were submitted for 
nutrient analysis to a commercial laboratory (Table 1) (Dairy One, Ithaca, NY).  
Access to fresh clean water and salt blocks containing only sodium chloride were 
available at all times.   
Weight Gain   
Horses were fed at maintenance for four weeks to allow for acclimation to the 
treatment diets, and then feeds were increased to weight gain intake levels over a 
period of one week.  Horses were fed for a targeted weight gain of 23 kg per three 
weeks, which was previously shown to result in a gain of one BCS score (Heusner, 
1993).  In order to achieve the targeted weight gain, hay and concentrate was fed to 
provide each horse with an additional 20 Mcal DE above their daily DE requirement 
for maintenance.  Horses were fed for weight gain over a period of eight months, 




seven Mcal DE was offered daily to each horse via concentrate at 1400 h in order to 
encourage an increase in ADG.   
Exercise 
Horses were exercised at a walk (1.5m/s) for 35 min twice daily on a six horse 
automated equine exerciser (Priefert, Mt. Pleasant, TX).  Horses were permanently 
assigned to one of three exercise groups, which were exercised in a random order, 
between 0900-1100 and 1630-1830.  A two week minimal exercise (MinEx) period 
occurred following the weight gain period of the study. 
Data Collection 
Horses were assessed for BCS (Henneke et al., 1983) at the end of the 
acclimation period, at the start of weight gain, and monthly thereafter.  Judges were 
selected based on knowledge of condition scoring and conducted their surveys 
independently of each other.  Body area condition scores as well as an overall score 
were determined for each horse at each time period.   
Blood samples were collected from each horse when they achieved a gain of 
one BCS, and before and after the minimal exercise period.  A total of 10ml blood 
was collected via jugular venipuncture into 10 ml uncoated Vacutainer tubes 
(Vacutainer, Becton Dickenson, Franklin Lakes, NJ), between 0700 and 0800, on 
days corresponding to BCS assessments.  Blood samples were allowed to clot for two 
hours and were then centrifuged at 15*g for 15 min at 4°C.  Serum was then divided 





Serum samples were analyzed for TNF concentrations using an enzyme linked 
immunosorbent assay (Equine TNFα Screening Set, Pierce, Rockford, IL) consisting 
of recombinant equine TNF, coating antibody, detection antibody, streptavidin HRP, 
substrate solution (3, 3’, 5, 5’- tetramethyl benzidine) and stop solution (0.18 M 
sulfuric acid).  Nunc-Immuno 96 MicroWell flat bottom plates coated with Maxisorb 
(Nalge Nunc International, Rochester, NY) were coated with 100 uL of 1.0 ug/ml 
coating antibody prepared in 0.2 M sodium carbonate-bicarbonate buffer (BupH 
Carbonate/Bicarbonate Buffer, Pierce, Rockford, IL) and allowed to incubate for 18 
hr.  After incubation, plates were blocked with a blocking buffer (BB) consisting of 
4% BSA (Albumin, Bovine Serum, Fraction V, RIA and ELISA grade, Calbiochem, 
La Jolla, CA), and 5% sucrose (Sucrose, Fisher Scientific, Fair Lawn, NJ), in PBS 
solution (BupH Modified Dulbecco’s Phosphate Buffered Saline Packs, Pierce, 
Rockford, IL), for 1 hr.  After blocking, the BB was aspirated and wells were rinsed 3 
times with 300 uL each of a wash buffer (WB) consisting of 0.05% Tween® 20 
(Tween® 20 Enzyme Grade, Fisher Scientific, Fair Lawn, NJ) in PBS.  After 
washing, 100 uL of sample or standard was added and incubated for one hr.  Then the 
wash step was repeated and 100 uL of 0.5 ug/ml detection antibody prepared in a 
reagent Diluents (RD) consisting of 4% BSA in PBS was added.  Detection antibody 
was incubated for 1 hr and then the wash step repeated a third time.  Next, 100 uL of 
streptavidin HRP (diluted 1:400 in RD), was added and incubated for 30 minutes.  
The wash step was repeated a fourth time and 100 uL of substrate solution was added 




the optical density (OD) values of each well were read in a plate reader (Tecan 
Sunrise, Phenix Research Products, Hayward, CA) at 450 and 550 nm.  The 550 nm 
reading was used as a correction factor and subtracted from the 450 nm reading for a 
final value.  Serum samples were assayed in duplicate at a 1:4 dilution in RD, and all 
samples with CV’s greater than 10% were re-assayed. 
Prior to running samples, the range of the standard curve, parallelism, and 
recovery were determined using pooled serum sample standards.  Sample standards 
consisted of pooled serum collected from the geldings at three BCS ranges 1) 3.5 to 
4.5, 2) 5 to 6, and 3) 6.5 to 7.5.  The standard curve was prepared from recombinant 
equine TNF in RD at concentrations of 1000, 500, 250, 125, 62.5, 31.25, 15.68, 7.81, 
3.91, 1.95, and 0.98 pg/ml, and assayed in triplicate.  The point at which the optical 
density (OD) values no longer declined with decreasing concentration was 
determined to be the limit of quantitation, and the lowest point on the standard curve 
for all future assays. 
One ml of each pooled sample was diluted 1:2, 1:4, 1:8, 1:16, and 1:32 in RD.  
All serum samples were vortexed 30s before diluting.  Samples were assayed neat, 
and at the above dilutions, in triplicate.  Parallelism was determined as the range of 
dilutions where the slopes of the pooled standards paralleled that of the standard 
curve.  Regions determined to be parallel were used to determine recovery.  Recovery 
was determined by diluting serum standards 1:4 in RD and then spiking with 1000 
pg/ml recombinant equine TNF.  Spiked samples were diluted parallel to the entire 
range of the standard curve.  In addition, a non-spiked sample was assayed at a 1:4 




sample was vortexed 30 s before diluting.  Recovery was determined as 
measured/predicted x 100%, where measured was the concentration determined from 
the OD value and predicted was the calculated concentration.  To assess effects of 
incubation time on TNF serum concentrations, samples from three horses were 
incubated for 15 m, 30 m, one hour and two hours, prior to centrifugation and storage 
of serum. 
The range of the standard curve was determined to be from 7.8 to 1000 pg/ml.  
Parallelism was confirmed between neat and the 1:4 dilutions, and recovery of spiked 
1:4 dilutions averaged 104%.  Results of spiking and recovery assay are represented 
in Table 3.  There was no difference in serum concentrations of TNF between 
samples that were incubated 15 m, 30 m, one hour, or two hours prior to 
centrifugation and storage of serum (data not shown).  Because there were no 
differences, the two hour incubation time was chosen. 
Statistical Analysis 
Body condition score data were analyzed by ANOVA with repeated measures 
using the mixed models procedure of SAS (SAS Institute Inc, Cary, NC), to 
determine the effects of time and diet on BCS.  Body weight data were analyzed by 
ANOVA with repeated measures, to determine the effects of time and diet on BW 
gain.  Digestible energy intakes between treatment groups within each month were 
analyzed by ANOVA.  Data for serum TNF was non-normal skewed right, and was 
therefore log10 transformed.  The effects of diet and BCS on serum TNF were 




Effects of incubation time on serum TNF concentrations were determined by 
ANOVA with repeated measures.  For all analyses, significance was set at P ≤ 0.05.   
RESULTS 
Average monthly digestible energy (DE) intakes were similar between dietary 
groups and shown in Table 2.  There was no effect of diet on either BW or BCS 
therefore means were combined and averaged across diets (Figure 1).  Body weight at 
the initiation of and at the end of weight gain was 519 ± 12 kg and 608 ± 12 kg, 
respectively.  Body condition score at the initiation of and at the end of weight gain 
was 4.3 ± 0.1 and 6.9 ± 0.1, respectively.  Removing exercise from the horse’s daily 
routine did not result in a change in BW or BCS (Figure 1).   
There was no main effect of diet on serum TNF concentrations, therefore 
means were combined and averaged across diets (Figure 2).  The mean TNF 
concentration for all horses over the entire study was 388.5 pg/mL (range 16.1 – 
1871.3 pg/mL).  There was a trend (P = 0.099) for the effect of BCS on serum TNF 
(Figure 2).  There was also a trend (P = 0.075) for an increase in TNF concentrations 
after two weeks of minimal exercise (Figure 3). 
DISCUSSION 
The association between weight gain and metabolic disorders was first 
identified in humans over 80 years ago (Carswell, 1923).  One of the theories relating 
obesity with the development of metabolic disturbances is that adipose tissue is a 
metabolically active tissue that produces and secretes several hormones and 
inflammatory proteins (Eckel, 2005; Despres, 2003; Duncan, 2001; Pickup, 2004).  In 




which in turn leads to the development of a low-grade systemic inflammation.  This 
systemic inflammation precludes the development of some metabolic diseases, such 
as insulin resistance and dyslipidemia (Permana et al., 2006; Skurk et al., 2004), 
making an increase in inflammation a predictor for the development of these 
metabolic disorders.  Similarly, metabolic disorders in horses and ponies have also 
been associated with adiposity (Kronfeld, 2006; Treiber et al., 2006), and recent 
research has come to focus on the role of inflammation in the development of these 
equine diseases (Vick et al., 2007). 
Accumulation of adipose tissue in obesity parallels an increased infiltration of 
macrophages (Weisberg et al., 2003; Wellen, 2003; Xu et al., 2003).  These 
macrophages are an important source of inflammatory protein production in adipose 
tissue through molecular signaling between adipocytes and macrophages (Weisberg 
et al., 2003; Xu et al., 2003).  Adipocytes produce two chemokines that affect 
macrophage infiltration into adipose tissue: macrophage migration inhibitory factor 
and monocyte chemoattractant protein-1 (Do et al., 2006).  The latter is involved with 
attracting and retaining macrophages in the adipose tissue and is significantly 
correlated to BMI, waist circumference, and other inflammatory markers in humans 
(Kim et al., 2006).   
Inflammation is indirectly measured by determining levels of different 
markers such as the pro-inflammatory cytokines and acute phase proteins 
(Salmenniemi et al., 2004; Schmidt et al., 1999).  The normal functions of the pro-
inflammatory cytokines are to initiate fever and increase energy availability through 




(Delano and Moldawer, 2006; Kawasaki et al., 1989; Saigusa, 1990).  In the case of 
sickness, the disruption of lipid and glucose metabolism is beneficial to fuel the 
increased metabolic rate and decreased food intake (Plata-Salaman, 1998).  Recovery 
from the infection restores normal metabolism (Tracey et al., 1988).  In the case of 
obesity, the continual upregulation of inflammation results in long term disrupted 
metabolism and the development of the metabolic diseases (Hardardottir et al., 1994; 
Hotamisligil, 1999).   
The pro-inflammatory cytokine, TNF has been used as a marker of 
inflammation and correlates directly with fat mass in humans (Dandonna et al., 1998; 
Samuelsson et al., 2003; and Ziccardi et al., 2002) and rodents (Hotamisligil et al., 
1993).  Remarkably, when injected intravenously into human subjects, TNF has 
initiated the development of insulin resistance (Krogh-Madsen et al., 2006; Plomgard 
et al., 2005).  Injection of TNF has also been associated with hypertriglyceridemia in 
dairy cows (Kushibiki et al., 2002).  We chose to study TNF as a marker of 
inflammation in horses because it has been extensively studied in other species and 
has not only been shown to increase with increasing adiposity but also to induce 
metabolic disruptions in those species. 
The first objective of this study was to assess inflammation in Thoroughbred 
geldings as they were fed for weight gain, as determined by serum concentrations of 
TNF.  We found that TNF concentrations did not increase when horses gained weight 
from BCS four to seven, in contrast to Vick et al. (2007).  Vick et al. (2007) 
performed a single assessment of mixed light breed mares between a BCS four to 




between a BCS of four to seven and were maintained in stalls.  Rather, a higher TNF 
concentration was found when horses were at a lower BCS of four in our study.  The 
higher TNF concentrations seen in the horses of BCS four could have been due to a 
negative energy balance, as increased concentrations of TNF have been shown to 
increase in human subjects carrying less than 80% of their ideal body weight (Allende 
et al., 1998).  The increased cytokine production in low body condition could be a 
metabolic adaptation to increase energy stores.  Tumor necrosis factor-α has catabolic 
effects on energy stores and may be increased in animals of low body condition in 
order to increase energy availability (Tracey et al., 1987).  The fact that there was no 
increase in TNF concentrations between a BCS of five, six, and seven may indicate 
that horses within this BCS range are at a healthy level of adiposity.   
The levels of TNF reported in this study were lower than those reported by 
Vick et al. (2007).  That study reported values ranging from 156 – 5000 pg/mL, 
whereas our concentrations were between 16.1 – 1833.8 pg/mL.  The higher TNF 
observed by Vick et al. (2007) is likely due to the higher BCS of the horses on their 
study, which included horses from a BCS four to nine.  In comparison, concentrations 
of TNF have been reported in the range of 3-18 pg/mL in humans (Dandona et al., 
1998; Samuelsson et al., 2004; Ziccardi et al., 2002), 150- 220 pg/mL in sheep 
(Daniel et al., 2003), and an average of 125 pg/mL in healthy steers (Kahl and 
Elsasser, 2006).  Normal levels of circulating levels of TNF in healthy animals may 
be species specific with concentrations in horses being higher than those found in 
other species.  Whether horses truly have a higher degree of inflammation in 




The second goal of this study was to determine the dietary effects of feeding a 
diet high in starch and sugar vs. a diet high in fat and fiber on inflammation.  High fat 
diets have previously been shown to induce an inflammatory state in rodents (De 
Souza et al., 2005).  This may be due to the increased availability of free fatty acids 
when consuming a high fat diet, as free fatty acids may induce TNF release from both 
adipocytes and macrophages (Suganami et al., 2005; 2007).  One possible reason for 
not seeing a dietary effect is that the 60:40 ratio of hay to grain reduced the overall 
percent fat in the diet (3.6% on the HS diet and 8.7% on the HF diet) to a level lower 
than that needed to effect a significant change in inflammation.   
The third goal of this study was to determine if the restriction of exercise 
would have an effect on inflammation in overweight horses, because horses that are 
diagnosed with metabolic disorders are often prescribed stall rest or are otherwise 
unable to exercise due to severe pain (Pollit, 1999).  The trend for increased TNF 
following exercise restriction seen in this study suggests that exercise may have a 
modulating effect on inflammation.  In humans, exercise often reduces inflammation 
(Kondo et al., 2005; Niessner et al., 2006) and this effect is possibly mediated through 
the effect of exercise increasing oxygen uptake.  However, the relationship between 
inflammation and oxidative status is not completely known.  In this study, the lack of 
a significant effect may due to the length of the exercise restriction being too short to 
have a significant influence on inflammatory status.   
Although the inter-assay CV for the TNF assay was at 5.5%, the intra-assay 
CV was higher than desired at 18.3%.  The large between-assay variability may be 




concentrations of diluted antibodies, recombinant TNF, or streptavidin HRP, as well 
as differences in the specificity of recombinant TNF between different vials of 
recombinant TNF.  A fresh standard of recombinant TNF was prepared for each plate 
unless plates were run on the same day, therefore standard degradation should not 
have been a source of variability, although there could have been slight differences 
between vials of recombinant TNF.  Secondly, preparations of carbonate-bicarbonate 
and RD were made up in 100 mL aliquots; therefore slight differences in 
concentrations may also have played a role, although buffers and reagents were made 
using the same balance, pipettes, and graduated cylinders to ensure as little variation 
as possible.  In future experiments buffers should be made up in a larger quantity or 
in the total volume needed to complete the entire experiment to ensure the least buffer 
variability.  Another possible source of variability is the differences in serum clotting 
time between the collection of the first and last serum samples.  Although samples 
were taken in a random order each collection time and centrifuged within two hours, 
there may have been differences in serum clot time between months depending on the 
number of staff available to collect blood samples. The effect of serum clotting time 
on TNF concentrations was evaluated using only three horses, and should be repeated 
on a different population of horses to ensure repeatability.  Another possible 
weakness of the assay is evidenced from the 104% average recovery, suggesting that 
there may be factors in the serum that the antibodies are measuring besides TNF. 
IMPLICATIONS 
Concentrations of TNF have been reported for clinically healthy TB geldings 




future studies.  Horses at a BCS of four and horses with minimal exercise may be at a 
higher risk of inflammation, and these relationships should be taken into 
consideration for future research.  Horses consuming a total dietary fat up to %8 are 
not at risk for increased inflammation.   
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Table 1.  Nutrient composition of a mixed grass/alfalfa hay (Hay) and either a 
concentrate high in starch and sugar (HS) or high in fiber and fat (HF) fed to horses1, 2 
            
Nutrient Hay Hay SEM HS HF 
Pooled 
SEM3 P-value4 
CP, % 14.4 1.0 10.0 10.1 0.6   0.965 
ADF, % 34.2 0.4   8.0 21.7 1.3 <0.001 
NDF, % 53.9 0.1 17.0 32.8 1.3 <0.001 
NSC5, % 14.2 0.1 56.7 20.1 1.4 <0.001 
Fat, %   3.1 0.8   4.3 17.2 0.9 <0.001 
Ash, %   7.0   0.02   4.6  7.4 0.5   0.001 
Ca, %   0.8       1.9   0.7  1.2 0.1   0.010 
P, %   0.3 1.5   0.3  0.3   0.03   0.041 
DE, Mcal/kg   1.0  0.02   3.6  2.9   0.03 <0.001 
DE, Mcal/kg6     3.6  3.5   
1
 DM basis as analyzed by Dairy One (Ithaca, NY)      
2 n = 15 for Hay; n = 9 for HS; n = 6 for HF 
3 SEM pooled for HS and HF concentrates 
4 Significance of differences between HS and HF concentrates 
5 Non-structural carbohydrates 
6 Theoretical DE value calculated based on the feed formulation, as proposed 




Table 2. Digestible energy (DE) intakes of horses fed for weight gain over an eight 
month period on a mixed grass/alfalfa hay and either a high in starch and sugar (HS) 
concentrate or a high in fat and fiber (HF) concentrate and then exercise restricted for 
two weeks (MinEx) 
        
 Concentrate  
Month HS HF 
P-
value 
 --- Mcal/d---  
Aug 18.0 ± 0.5 18.2 ± 0.5 0.735 
Sep 35.8 ± 0.5 34.8 ± 0.5 0.946 
Oct 33.4 ± 1.0 32.1 ± 1.1 0.414 
Nov 35.1 ± 1.7 32.7 ± 1.8 0.349 
Dec 39.2 ± 2.0 37.5 ± 2.2 0.576 
Jan 33.0 ± 1.6 28.3 ± 1.7 0.066 
Fen 34.6 ± 1.9 31.5 ± 2.0 0.286 
Mar 36.5 ± 2.7 32.7 ± 2.9 0.347 
Apr 36.0 ± 2.1 30.5 ± 2.2 0.091 






Table 3.  Recovery of tumor necrosis factor-α (TNF) from serum of horses from 
varied body condition scores (BCS) after spiking with recombinant equine TNF and 
dilutional parallelism of an ELISA specific for equine TNF (Endogen, Pierce, 
Rockford, IL) 1 
                      











pg/ml R, % O, pg/ml 
E, 
pg/ml R, % 
1:4 0     1.2 - -   27.6 - -   71.6 - - 
1:4 1000.0 848.8 1001.2   84.8 884.5 1027.6   86.1 919.1 1071.6   85.8 
1:8   500.0 481.6   501.3   96.1 547.0   529.1 103.4 625.7   575.6 108.7 
1:16   250.0 255.7   251.3 101.8 302.5   279.9 108.1 372.5   327.6 113.7 
1:32   125.0 129.3   126.3 102.4 181.4   156.0 116.3 230.0   203.6 113.0 
1:64     62.5   66.4     63.9 103.9   99.5     93.0 107.0 160.2   141.6 113.1 
1:128     31.3   35.7     32.6 109.5   64.5    61.8 104.4 121.8   110.5 110.2 
1:256     15.6   20.0     17.0 117.6   50.2    46.2 108.7 104.5     95.1 109.9 
1 O=observed concentrations; E=expected concentrations; R=percent recovery 







Figure 1.  Body condition scores (BCS) and body weight (BW) of horses fed for 
weight gain on a mixed grass/alfalfa hay and either a concentrate high in starch and 
sugar or high in fat and fiber.  A two week minimal exercise period (MinEx) followed 
the weight gain period.  Monthly means are averaged across diets and represented as 
mean ± SE.  a,b,c,d, e, f, g Means with unlike superscripts within either BCS or BW differ 
















Figure 2.  Effects of body condition score (BCS) on serum tumor necrosis factor-α 
(TNF) concentrations of horses fed for weight gain on a mixed grass/alfalfa hay and 
either a high in starch and sugar or a high in fat and fiber diet.  Geometric means are 
averaged across diets and represented as mean ± SE.  a, b Means with unlike 








Figure 3. The effects of exercise restriction on serum tumor necrosis factor-α (TNF) 
concentrations of horses fed for weight gain on a mixed grass/alfalfa hay and either a 
high in starch and sugar or a high in fat and fiber diet.  Geometric means are averaged 
across diets and represented as mean ± SE.  There was a trend for increased TNF after 





Chapter 5:  General Summary 
 
 The main objectives of these studies were to assess the effects of weight gain 
and diet on body condition scoring in Thoroughbred (TB) geldings as well as to 
assess the effects of weight gain, diet and exercise on inflammation in the horse as 
indicated by serum concentrations of the pro-inflammatory cytokine, tumor necrosis 
factor-α (TNF).  For these studies, fifteen TB geldings were fed for weight gain on 
hay plus either a high in starch and sugar (HS) concentrate or a high in fat and fiber 
(HF) concentrate over an eight month period.  Monthly body area (neck, withers, 
shoulders, ribs, loin, and tailhead) body condition scores (BCS) were recorded by two 
judges, and blood was analyzed for serum TNF concentrations.  The BCS method 
used was that of Henneke et al. (1983). 
 We found no dietary effect on body area body condition score, but there were 
significant differences between body area scores within months.  Neck scored 
consistently higher than both withers and loin, while shoulders, ribs, and tailhead 
agreed during most monthly assessments.  Additionally, the agreement between the 
two judge’s scores was not consistent across either time periods or body areas, 
indicating the subjective nature of body condition scoring.  The withers and loin were 
two areas that may be most influenced by conformation and should therefore be 
removed from BCS scoring.  Several equations able to accurately predict the mean 




recommendation of one above all others will require assessment on a different 
population of horses. 
 In the second study, the eight month weight gain period was followed by two 
weeks of no exercise.  There was no dietary effect on serum TNF concentrations, 
while horses in low body condition had higher TNF concentrations than horses in 
high body condition.  Restricting exercise tended to increase TNF concentrations.   
These findings imply that horses in low body condition as well as those with minimal 
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